reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason,PUBMED_ID_TITLE_AUTHORS,PUBMED_ID_TITLE,PUBMED_ID_S2,N_CITATIONS,S2_PDF_LINK,CORE_PDF_LINK,PUBMED_ID
CD014884-bib-0001,"Barron KS, Murphy DJ Jr, Silverman ED, Ruttenberg HD, Wright GB, Franklin W, et al. ",Treatment of Kawaski syndrome: a comparison of two dosage regimens of intravenously administered immune globulin, Journal of Pediatrics ,1990,117,    ,['citation-journal']," Barron KS, Murphy DJ Jr, Silverman ED, Ruttenberg HD, Wright GB, Franklin W, et al. Treatment of Kawaski syndrome: a comparison of two dosage regimens of intravenously administered immune globulin.  Journal of Pediatrics 1990;117(4):638-44. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0022-3476(05)80707-3', 'https://www.ncbi.nlm.nih.gov/pubmed/2213395', 'https://scholar.google.com/scholar_lookup?title=Treatment+of+Kawaski+syndrome:+a+comparison+of+two+dosage+regimens+of+intravenously+administered+immune+globulin+&author=KS+Barron&author=ED+Silverman&author=HD+Ruttenberg&author=GB+Wright&author=W+Franklin&publication_year=1990&hl=en']",2213395,https://doi.org/10.1016/S0022-3476(05)80707-3, Barron 1990 {published data only}  ,included,CD014884-bbs2-0001,,,,2213395,66.0,,,2213395
CD014884-bib-0002,"Burns JC, Connor JD, Capparelli EV, Best BM, Mejias A, Mahony L, et al. ",Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease, Journal of Pediatrics ,2008,153,    ,['citation-journal']," Burns JC, Connor JD, Capparelli EV, Best BM, Mejias A, Mahony L, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.  Journal of Pediatrics 2008;153(6):833-8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.jpeds.2008.06.011', 'https://www.ncbi.nlm.nih.gov/pubmed/18672254', 'https://scholar.google.com/scholar_lookup?title=Infliximab+treatment+of+intravenous+immunoglobulin-resistant+Kawasaki+disease&author=JC+Burns&author=JD+Connor&author=EV+Capparelli&author=BM+Best&author=A+Mejias&author=L+Mahony&publication_year=2008&hl=en']",18672254,https://doi.org/10.1016/j.jpeds.2008.06.011, Burns 2008 {published data only}  ,included,CD014884-bbs2-0002,,,,18672254,248.0,https://europepmc.org/articles/pmc2856847?pdf=render,,18672254
CD014884-bib-0003,NCT00271570. ,Infliximab (Remicade) for patients with acute Kawasaki disease,,,,   ,['citation-other'], NCT00271570. Infliximab (Remicade) for patients with acute Kawasaki disease. clinicaltrials.gov/show/NCT00271570 (first received 2 January 2006). CENTRAL    ,[''],,, Burns 2008 {published data only}  ,included,CD014884-bbs2-0002,,,,,,,,
CD014884-bib-0004,"Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, et al. ","Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial", Lancet Child and Adolescent Health ,2021,5,    ,['citation-journal']," Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.  Lancet Child and Adolescent Health 2021;5(12):852-61. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S2352-4642(21)00270-4', 'https://www.ncbi.nlm.nih.gov/pubmed/34715057', 'https://scholar.google.com/scholar_lookup?title=Infliximab+versus+second+intravenous+immunoglobulin+for+treatment+of+resistant+Kawasaki+disease+in+the+USA+(KIDCARE):+a+randomised,+multicentre+comparative+effectiveness+trial+&author=JC+Burns&author=SC+Roberts&author=AH+Tremoulet&author=F+He&author=BF+Printz&author=N+Ashouri&publication_year=2021&hl=en']",34715057,https://doi.org/10.1016/S2352-4642(21)00270-4, Burns 2021 {published data only}  ,included,CD014884-bbs2-0003,,,34715057,34715057,61,http://www.thelancet.com/article/S2352464221002704/pdf,,34715057
CD014884-bib-0005,NCT03065244. ,KIDCARE (Kawasaki Disease Comparative Effectiveness Trial),,,,   ,['citation-other'], NCT03065244. KIDCARE (Kawasaki Disease Comparative Effectiveness Trial). clinicaltrials.gov/show/NCT03065244 (first received 27 February 2017). CENTRAL    ,[''],,, Burns 2021 {published data only}  ,included,CD014884-bbs2-0003,,34715057,,,,,,34715057
CD014884-bib-0006,"Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC, KIDCARE Multicenter Study Group. ","The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: a phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease", Contemporary Clinical Trials ,2019,79,    ,['citation-journal']," Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC, KIDCARE Multicenter Study Group. The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: a phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.  Contemporary Clinical Trials 2019;79:98-103. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.cct.2019.02.008', 'https://www.ncbi.nlm.nih.gov/pubmed/30840903', 'https://scholar.google.com/scholar_lookup?title=The+Kawasaki+Disease+Comparative+Effectiveness+(KIDCARE)+trial:+a+phase+III,+randomized+trial+of+second+intravenous+immunoglobulin+versus+infliximab+for+resistant+Kawasaki+disease+&author=SC+Roberts&author=S+Jain&author=AH+Tremoulet&author=KK+Kim&author=JC+Burns&publication_year=2019&hl=en']",30840903,https://doi.org/10.1016/j.cct.2019.02.008, Burns 2021 {published data only}  ,included,CD014884-bbs2-0003,,,,30840903,24,https://scholarworks.indianapolis.iu.edu/bitstreams/40243e7d-3803-4512-a460-b658920929ea/download,,30840903
CD014884-bib-0007,"Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. ",Intravenous gamma-globulin for Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1991,33,    ,['citation-journal']," Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. Intravenous gamma-globulin for Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1991;33(6):799-804. CENTRAL [DOI: 10.1111/j.1442-200x.1991.tb02611.x]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1442-200X.1991.tb02611.x', 'https://www.ncbi.nlm.nih.gov/pubmed/1801560', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma-globulin+for+Kawasaki+disease&author=K+Furusho&author=T+Kamiya&author=H+Nakano&author=N+Kiyosawa&author=K+Shinomiya&author=T+Hayashidera&publication_year=1991&hl=en']",1801560,https://doi.org/10.1111/j.1442-200X.1991.tb02611.x, Furusho 1984 {published data only}  ,included,CD014884-bbs2-0004,,,,,27,,,1801560
CD014884-bib-0008,"Furusho K, Kamiya T, Nakano H. ",High-dose intravenous gammaglobulin for Kawasaki disease, Lancet ,1984,2,    ,['citation-journal']," Furusho K, Kamiya T, Nakano H. High-dose intravenous gammaglobulin for Kawasaki disease.  Lancet 1984;2(8411):1055-8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(84)91504-6', 'https://www.ncbi.nlm.nih.gov/pubmed/6209513', 'https://scholar.google.com/scholar_lookup?title=High-dose+intravenous+gammaglobulin+for+Kawasaki+disease&author=K+Furusho&author=T+Kamiya&author=H+Nakano&publication_year=1984&hl=en']",6209513,https://doi.org/10.1016/S0140-6736(84)91504-6, Furusho 1984 {published data only}  ,included,CD014884-bbs2-0004,,6209513,,6209513,475,,,6209513
CD014884-bib-0009,"Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. ",Intravenous gamma-globulin for Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1991,33,    ,['citation-journal']," Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. Intravenous gamma-globulin for Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1991;33(6):799-804. CENTRAL [DOI: 10.1111/j.1442-200x.1991.tb02611.x]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1442-200X.1991.tb02611.x', 'https://www.ncbi.nlm.nih.gov/pubmed/1801560', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma-globulin+for+Kawasaki+disease&author=K+Furusho&author=T+Kamiya&author=H+Nakano&author=N+Kiyosawa&author=K+Shinomiya&author=T+Hayashidera&publication_year=1991&hl=en']",1801560,https://doi.org/10.1111/j.1442-200X.1991.tb02611.x, Furusho 1991A {published data only}  ,included,CD014884-bbs2-0005,,,,,27,,,1801560
CD014884-bib-0010,"Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. ",Intravenous gamma-globulin for Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1991,33,    ,['citation-journal']," Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. Intravenous gamma-globulin for Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1991;33(6):799-804. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1442-200X.1991.tb02611.x', 'https://www.ncbi.nlm.nih.gov/pubmed/1801560', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma-globulin+for+Kawasaki+disease&author=K+Furusho&author=T+Kamiya&author=H+Nakano&author=N+Kiyosawa&author=K+Shinomiya&author=T+Hayashidera&publication_year=1991&hl=en']",1801560,https://doi.org/10.1111/j.1442-200X.1991.tb02611.x, Furusho 1991B {published data only}  ,included,CD014884-bbs2-0006,,,,,27,,,1801560
CD014884-bib-0011,"Harada H, Yamaguchi H. ",Intravenous gamma globulin treatment in Kawasaki disease - comparison between high dose and low dose, Progress in Medicine ,1989,9,    ,['citation-journal']," Harada H, Yamaguchi H. Intravenous gamma globulin treatment in Kawasaki disease - comparison between high dose and low dose.  Progress in Medicine 1989;9:45-8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma+globulin+treatment+in+Kawasaki+disease+-+comparison+between+high+dose+and+low+dose+&author=H+Harada&author=H+Yamaguchi&publication_year=1989&hl=en']",,, Harada 1989 {published data only}  ,included,CD014884-bbs2-0007,,,,,,,,
CD014884-bib-0012,Harada K. ,Intravenous gamma-globulin treatment in Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1991,33,    ,['citation-journal'], Harada K. Intravenous gamma-globulin treatment in Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1991;33(6):805-10. CENTRAL    Link to article     PubMed     Google Scholar     ,"['', 'https://doi.org/10.1111/j.1442-200X.1991.tb02612.x', 'https://www.ncbi.nlm.nih.gov/pubmed/1801561', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma-globulin+treatment+in+Kawasaki+disease&author=K+Harada&publication_year=1991&hl=en']",1801561,https://doi.org/10.1111/j.1442-200X.1991.tb02612.x, Harada 1989 {published data only}  ,included,CD014884-bbs2-0007,,16215725,,,208,,,1801561
CD014884-bib-0013,"Hashino K, Ishii M, Iemura M, Akagi T, Kato H. ",Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy, Pediatrics International ,2001,43,    ,['citation-journal']," Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.  Pediatrics International 2001;43(3):211-7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1442-200x.2001.01373.x', 'https://www.ncbi.nlm.nih.gov/pubmed/11380911', 'https://scholar.google.com/scholar_lookup?title=Re-treatment+for+immune+globulin-resistant+Kawasaki+disease:+a+comparative+study+of+additional+immune+globulin+and+steroid+pulse+therapy+&author=K+Hashino&author=M+Ishii&author=M+Iemura&author=T+Akagi&author=H+Kato&publication_year=2001&hl=en']",11380911,https://doi.org/10.1046/j.1442-200x.2001.01373.x, Hashino 2001 {published data only}  ,included,CD014884-bbs2-0008,,11380911,11380911,11380911,165,,,11380911
CD014884-bib-0014,"He L, Liu F, Huang G. ",Multi centeral study on IVIG treatment to Kawasaki disease, Cardiology in the Young ,2017,27,    ,['citation-journal']," He L, Liu F, Huang G. Multi centeral study on IVIG treatment to Kawasaki disease.  Cardiology in the Young 2017;27(4):S472. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Multi+centeral+study+on+IVIG+treatment+to+Kawasaki+disease&author=L+He&author=F+Liu&author=G+Huang&publication_year=2017&hl=en']",,, He 2021 {published data only}  ,included,CD014884-bbs2-0009,,,,,,,,
CD014884-bib-0015,"He L, Liu F, Yan W, Huang M, Huang M, Xie L, et al. ",Randomized trial of different initial IVIG regimens in Kawasaki disease, Pediatrics International ,2021,63,    ,['citation-journal']," He L, Liu F, Yan W, Huang M, Huang M, Xie L, et al. Randomized trial of different initial IVIG regimens in Kawasaki disease.  Pediatrics International 2021;63(7):757-63. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/ped.14656', 'https://www.ncbi.nlm.nih.gov/pubmed/33600060', 'https://scholar.google.com/scholar_lookup?title=Randomized+trial+of+different+initial+IVIG+regimens+in+Kawasaki+disease&author=L+He&author=F+Liu&author=W+Yan&author=M+Huang&author=M+Huang&author=L+Xie&publication_year=2021&hl=en']",33600060,https://doi.org/10.1111/ped.14656, He 2021 {published data only}  ,included,CD014884-bbs2-0009,,,,33600060,15,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ped.14656,,33600060
CD014884-bib-0016,"He L, Niu CW, Liu F, Huang GY, Wu L, Chu C, et al. ",A prospective randomised study of intravenous immunoglobulin treatment regimens in acute Kawasaki disease, Journal of the Hong Kong College of Cardiology ,2016,24,    ,['citation-journal']," He L, Niu CW, Liu F, Huang GY, Wu L, Chu C, et al. A prospective randomised study of intravenous immunoglobulin treatment regimens in acute Kawasaki disease.  Journal of the Hong Kong College of Cardiology 2016;24(1):49. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+prospective+randomised+study+of+intravenous+immunoglobulin+treatment+regimens+in+acute+Kawasaki+disease+&author=L+He&author=CW+Niu&author=F+Liu&author=GY+Huang&author=L+Wu&author=C+Chu&publication_year=2016&hl=en']",,, He 2021 {published data only}  ,included,CD014884-bbs2-0009,,,,,,,,
CD014884-bib-0017,NCT02439996. ,Different doses of IVIG for Kawasaki disease,,,,   ,['citation-other'], NCT02439996. Different doses of IVIG for Kawasaki disease. clinicaltrials.gov/show/NCT02439996 (first received 12 May 2015). CENTRAL    ,[''],,, He 2021 {published data only}  ,included,CD014884-bbs2-0009,,,,,,,,
CD014884-bib-0018,"Matsushima M, Nagashima M, Matsuoka H. ",High dose immunoglobulin therapy for Kawasaki disease by a control study, Nihon Shounika Gakkai Zasshi [Journal of the Japanese Pediatric Society] ,1986,90,    ,['citation-journal']," Matsushima M, Nagashima M, Matsuoka H. High dose immunoglobulin therapy for Kawasaki disease by a control study.  Nihon Shounika Gakkai Zasshi [Journal of the Japanese Pediatric Society] 1986;90:80-7. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=High+dose+immunoglobulin+therapy+for+Kawasaki+disease+by+a+control+study&author=M+Matsushima&author=M+Nagashima&author=H+Matsuoka&publication_year=1986&hl=en']",,, Matsushima 1985 {published data only}  ,included,CD014884-bbs2-0010,,2437278,,,,,,2437278
CD014884-bib-0019,"Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M. ",Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin, European Journal of Pediatrics ,2008,167,    ,['citation-journal']," Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.  European Journal of Pediatrics 2008;167(10):1119-23. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s00431-007-0642-5', 'https://www.ncbi.nlm.nih.gov/pubmed/18175148', 'https://scholar.google.com/scholar_lookup?title=Effects+of+methylprednisolone+pulse+on+cytokine+levels+in+Kawasaki+disease+patients+unresponsive+to+intravenous+immunoglobulin+&author=M+Miura&author=K+Kohno&author=H+Ohki&author=S+Yoshiba&author=A+Sugaya&author=M+Satoh&publication_year=2008&hl=en']",18175148,https://doi.org/10.1007/s00431-007-0642-5, Miura 2008 {published data only}  ,included,CD014884-bbs2-0011,,18175148,18175148,18175148,50,,,18175148
CD014884-bib-0020,"Miura M, Ohki H, Yoshiba S, Ueda H, Sugaya A, Satoh M, et al. ",Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease, Archives of Disease in Childhood ,2005,90,    ,['citation-journal']," Miura M, Ohki H, Yoshiba S, Ueda H, Sugaya A, Satoh M, et al. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.  Archives of Disease in Childhood 2005;90(10):1096-7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1136/adc.2004.062299', 'https://www.ncbi.nlm.nih.gov/pubmed/16177169', 'https://scholar.google.com/scholar_lookup?title=Adverse+effects+of+methylprednisolone+pulse+therapy+in+refractory+Kawasaki+disease&author=M+Miura&author=H+Ohki&author=S+Yoshiba&author=H+Ueda&author=A+Sugaya&author=M+Satoh&publication_year=2005&hl=en']",16177169,https://doi.org/10.1136/adc.2004.062299, Miura 2008 {published data only}  ,included,CD014884-bbs2-0011,,,,16177169,95,https://adc.bmj.com/content/archdischild/90/10/1096.full.pdf,,16177169
CD014884-bib-0021,"Mori M, Hara T, Kikuchi M, Shimizu H, Miyamoto T, Iwashima S, et al. ","Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial", Scientific Reports ,2018,8,    ,['citation-journal']," Mori M, Hara T, Kikuchi M, Shimizu H, Miyamoto T, Iwashima S, et al. Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial.  Scientific Reports 2018;8(1):1994. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1038/s41598-017-18387-7', 'https://www.ncbi.nlm.nih.gov/pubmed/29386515', 'https://scholar.google.com/scholar_lookup?title=Infliximab+versus+intravenous+immunoglobulin+for+refractory+Kawasaki+disease:+a+phase+3,+randomized,+open-label,+active-controlled,+parallel-group,+multicenter+trial+&author=M+Mori&author=T+Hara&author=M+Kikuchi&author=H+Shimizu&author=T+Miyamoto&author=S+Iwashima&publication_year=2018&hl=en']",29386515,https://doi.org/10.1038/s41598-017-18387-7, Mori 2017 {published data only}  ,included,CD014884-bbs2-0012,,,29386515,29386515,73,https://www.nature.com/articles/s41598-017-18387-7.pdf,,29386515
CD014884-bib-0022,Mori M. ,Clinical trial of the infliximab for Kawasaki disease that an effect is inadequate for by existing treatment in Japan,,2017,56,    ,['citation-other'], Mori M. Clinical trial of the infliximab for Kawasaki disease that an effect is inadequate for by existing treatment in Japan. Rheumatology (United Kingdom)2017;56(Suppl 3):P1-67. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Clinical+trial+of+the+infliximab+for+Kawasaki+disease+that+an+effect+is+inadequate+for+by+existing+treatment+in+Japan+&author=M+Mori&publication_year=2017&hl=en']",,, Mori 2017 {published data only}  ,included,CD014884-bbs2-0012,,,,,,,,
CD014884-bib-0023,NCT01596335. ,Clinical study of TA-650 in patients with refractory Kawasaki disease,,,,   ,['citation-other'], NCT01596335. Clinical study of TA-650 in patients with refractory Kawasaki disease. clinicaltrials.gov/ct2/show/NCT01596335 (first received 26 September 2018). CENTRAL    ,[''],,, Mori 2017 {published data only}  ,included,CD014884-bbs2-0012,,29386515,,,,,,29386515
CD014884-bib-0024,"Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, et al. ","A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease", Acta Paediatrica Japonica: Overseas edition ,1994,36,    ,['citation-journal']," Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, et al. A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1994;36(4):347-54. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1442-200X.1994.tb03199.x', 'https://www.ncbi.nlm.nih.gov/pubmed/7524263', 'https://scholar.google.com/scholar_lookup?title=A+multicenter,+randomized,+controlled+trial+of+intravenous+gamma+globulin+therapy+in+children+with+acute+Kawasaki+disease+&author=Y+Morikawa&author=Y+Ohashi&author=K+Harada&author=T+Asai&author=S+Okawa&author=M+Nagashima&publication_year=1994&hl=en']",7524263,https://doi.org/10.1111/j.1442-200X.1994.tb03199.x, Morikawa 1994 {published data only}  ,included,CD014884-bbs2-0013,,,,7524263,31,,,7524263
CD014884-bib-0025,"Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, et al. ",Coronary risks after high-dose gamma-globulin in children with Kawasaki disease, Pediatrics International ,2000,42,    ,['citation-journal']," Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, et al. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease.  Pediatrics International 2000;42(5):464-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1442-200x.2000.01288.x', 'https://www.ncbi.nlm.nih.gov/pubmed/11059532', 'https://scholar.google.com/scholar_lookup?title=Coronary+risks+after+high-dose+gamma-globulin+in+children+with+Kawasaki+disease&author=Y+Morikawa&author=Y+Ohashi&author=K+Harada&author=T+Asai&author=S+Okawa&author=M+Nagashima&publication_year=2000&hl=en']",11059532,https://doi.org/10.1046/j.1442-200x.2000.01288.x, Morikawa 1994 {published data only}  ,included,CD014884-bbs2-0013,,,,,23,,,11059532
CD014884-bib-0026,"Nagashima M, Matsushima M, Matsuoka H. ",High-dose gammaglobulin therapy for Kawasaki disease, Journal of Pediatrics ,1987,110,    ,['citation-journal']," Nagashima M, Matsushima M, Matsuoka H. High-dose gammaglobulin therapy for Kawasaki disease.  Journal of Pediatrics 1987;110(5):710-2. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0022-3476(87)80007-0', 'https://www.ncbi.nlm.nih.gov/pubmed/2437278', 'https://scholar.google.com/scholar_lookup?title=High-dose+gammaglobulin+therapy+for+Kawasaki+disease&author=M+Nagashima&author=M+Matsushima&author=H+Matsuoka&publication_year=1987&hl=en']",2437278,https://doi.org/10.1016/S0022-3476(87)80007-0, Nagashima 1987 {published data only}  ,included,CD014884-bbs2-0014,,2437278,,2437278,99,,,2437278
CD014884-bib-0027,"Newburger JW, Takahashi M, Burns JC. ",The treatment of Kawasaki syndrome with intravenous gamma globulin, New England Journal of Medicine ,1986,315,    ,['citation-journal']," Newburger JW, Takahashi M, Burns JC. The treatment of Kawasaki syndrome with intravenous gamma globulin.  New England Journal of Medicine 1986;315(6):341-7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM198608073150601', 'https://www.ncbi.nlm.nih.gov/pubmed/2426590', 'https://scholar.google.com/scholar_lookup?title=The+treatment+of+Kawasaki+syndrome+with+intravenous+gamma+globulin&author=JW+Newburger&author=M+Takahashi&author=JC+Burns&publication_year=1986&hl=en']",2426590,https://doi.org/10.1056/NEJM198608073150601, Newburger 1986 {published data only}  ,included,CD014884-bbs2-0015,,15574639,,,1355,,,2426590
CD014884-bib-0028,"Takahashi M, Newburger JW. ",Long-term follow-up of coronary abnormalities in Kawasaki syndrome treated with and without IV gamma globulin, Circulation ,1990,82,    ,['citation-journal']," Takahashi M, Newburger JW. Long-term follow-up of coronary abnormalities in Kawasaki syndrome treated with and without IV gamma globulin.  Circulation 1990;82:717. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Long-term+follow-up+of+coronary+abnormalities+in+Kawasaki+syndrome+treated+with+and+without+IV+gamma+globulin+&author=M+Takahashi&author=JW+Newburger&publication_year=1990&hl=en']",,, Newburger 1986 {published data only}  ,included,CD014884-bbs2-0015,,,,,,,,
CD014884-bib-0029,NCT00000520. ,Prevention of coronary aneurysms in Kawasaki syndrome,,,,   ,['citation-other'], NCT00000520. Prevention of coronary aneurysms in Kawasaki syndrome. clinicaltrials.gov/show/NCT00000520 (first received 28 October 1999). CENTRAL    ,[''],,, Newburger 1991 {published data only}  ,included,CD014884-bbs2-0016,,,,,,,,
CD014884-bib-0030,"Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. ",A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome, New England Journal of Medicine ,1991,324,    ,['citation-journal']," Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.  New England Journal of Medicine 1991;324(23):1633-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM199106063242305', 'https://www.ncbi.nlm.nih.gov/pubmed/1709446', 'https://scholar.google.com/scholar_lookup?title=A+single+intravenous+infusion+of+gamma+globulin+as+compared+with+four+infusions+in+the+treatment+of+acute+Kawasaki+syndrome+&author=JW+Newburger&author=M+Takahashi&author=AS+Beiser&author=JC+Burns&author=J+Bastian&author=KJ+Chung&publication_year=1991&hl=en']",1709446,https://doi.org/10.1056/NEJM199106063242305, Newburger 1991 {published data only}  ,included,CD014884-bbs2-0016,,,1709446,1709446,1133,https://www.nejm.org/doi/pdf/10.1056/NEJM199106063242305?articleTools=true,,1709446
CD014884-bib-0031,"Nishihara S, Ishibashi K, Matsuda I. ",Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki disease, Lancet ,1988,2,    ,['citation-journal']," Nishihara S, Ishibashi K, Matsuda I. Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki disease.  Lancet 1988;2(8617):973. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(88)92650-5', 'https://www.ncbi.nlm.nih.gov/pubmed/2459575', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gammaglobulin+and+reduction+of+coronary+artery+abnormalities+in+children+with+Kawasaki+disease+&author=S+Nishihara&author=K+Ishibashi&author=I+Matsuda&publication_year=1988&hl=en']",2459575,https://doi.org/10.1016/S0140-6736(88)92650-5, Nishihara 1988 {published data only}  ,included,CD014884-bbs2-0017,,2459575,,2459575,9,,,2459575
CD014884-bib-0032,"Nonaka Z, Maekawa K, Okabe T, Eto Y, Kubo M. ",Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki disease,,1995,,    ,['citation-other']," Nonaka Z, Maekawa K, Okabe T, Eto Y, Kubo M. Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki disease. Kawasaki Disease1995:328-31. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Randomized+controlled+study+of+intravenous+prednisolone+and+gammaglobulin+treatment+in+100+cases+with+Kawasaki+disease+&author=Z+Nonaka&author=K+Maekawa&author=T+Okabe&author=Y+Eto&author=M+Kubo&publication_year=1995&hl=en']",,, Nonaka 1995 {published data only}  ,included,CD014884-bbs2-0018,,,,,,,,
CD014884-bib-0033,"Ogawa M, Ogino H, Harima Y, Kono S, Ohkuni H, Nishida M. ",High dose gamma-globulin therapy for Kawasaki disease, Journal of the Japanese Pediatric Society ,1987,91,    ,['citation-journal']," Ogawa M, Ogino H, Harima Y, Kono S, Ohkuni H, Nishida M. High dose gamma-globulin therapy for Kawasaki disease.  Journal of the Japanese Pediatric Society 1987;91(12):3763-71. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=High+dose+gamma-globulin+therapy+for+Kawasaki+disease&author=M+Ogawa&author=H+Ogino&author=Y+Harima&author=S+Kono&author=H+Ohkuni&author=M+Nishida&publication_year=1987&hl=en']",,, Ogawa 1987 {published data only}  ,included,CD014884-bbs2-0019,,,,,,,,
CD014884-bib-0034,"Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. ",Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease, Progress in Clinical and Biological Research ,1987,250,    ,['citation-journal']," Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease.  Progress in Clinical and Biological Research 1987;250:555-6. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/3321085', 'https://scholar.google.com/scholar_lookup?title=Clinical+evaluation+of+gammaglobulin+preparations+for+the+treatment+of+Kawasaki+disease&author=H+Ogino&author=M+Ogawa&author=Y+Harima&author=S+Kono&author=H+Ohkuni&author=M+Nishida&publication_year=1987&hl=en']",3321085,, Ogawa 1987 {published data only}  ,included,CD014884-bbs2-0019,,,3321085,,,,,3321085
CD014884-bib-0035,"Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. ",High-dose intravenous gammaglobulin treatment of Kawasaki disease, Progress in Medicine ,1990,10,    ,['citation-journal']," Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. High-dose intravenous gammaglobulin treatment of Kawasaki disease.  Progress in Medicine 1990;10:29-38. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=High-dose+intravenous+gammaglobulin+treatment+of+Kawasaki+disease&author=H+Ogino&author=M+Ogawa&author=Y+Harima&author=S+Kono&author=H+Ohkuni&author=M+Nishida&publication_year=1990&hl=en']",,, Ogawa 1987 {published data only}  ,included,CD014884-bbs2-0019,,,,,,,,
CD014884-bib-0036,"Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. ",Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease, Progress in Clinical and Biological Research ,1987,250,    ,['citation-journal']," Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease.  Progress in Clinical and Biological Research 1987;250:555-6. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/3321085', 'https://scholar.google.com/scholar_lookup?title=Clinical+evaluation+of+gammaglobulin+preparations+for+the+treatment+of+Kawasaki+disease&author=H+Ogino&author=M+Ogawa&author=Y+Harima&author=S+Kono&author=H+Ohkuni&author=M+Nishida&publication_year=1987&hl=en']",3321085,, Ogino 1987 {published data only}  ,included,CD014884-bbs2-0020,,,3321085,,,,,3321085
CD014884-bib-0037,"Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. ",High-dose intravenous gammaglobulin treatment of Kawasaki disease, Progress in Medicine ,1990,10,    ,['citation-journal']," Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. High-dose intravenous gammaglobulin treatment of Kawasaki disease.  Progress in Medicine 1990;10:29-38. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=High-dose+intravenous+gammaglobulin+treatment+of+Kawasaki+disease&author=H+Ogino&author=M+Ogawa&author=Y+Harima&author=S+Kono&author=H+Ohkuni&author=M+Nishida&publication_year=1990&hl=en']",,, Ogino 1987 {published data only}  ,included,CD014884-bbs2-0020,,,,,,,,
CD014884-bib-0038,"Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nisida M. ",Clinical evaluation of gamma globulin preparations for the treatment of Kawasaki disease - trial of 200 mg/kg/day, Journal of the Japanese Pediatric Society ,1987,91,    ,['citation-journal']," Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nisida M. Clinical evaluation of gamma globulin preparations for the treatment of Kawasaki disease - trial of 200 mg/kg/day.  Journal of the Japanese Pediatric Society 1987;91(8):2849-56. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Clinical+evaluation+of+gamma+globulin+preparations+for+the+treatment+of+Kawasaki+disease+-+trial+of+200+mg/kg/day+&author=H+Ogino&author=M+Ogawa&author=Y+Harima&author=S+Kono&author=H+Ohkuni&author=M+Nisida&publication_year=1987&hl=en']",,, Ogino 1987 {published data only}  ,included,CD014884-bbs2-0020,,,,,,,,
CD014884-bib-0039,Harada K. ,Intravenous gamma-globulin treatment in Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1991,33,    ,['citation-journal'], Harada K. Intravenous gamma-globulin treatment in Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1991;33(6):805-10. CENTRAL    Link to article     PubMed     Google Scholar     ,"['', 'https://doi.org/10.1111/j.1442-200X.1991.tb02612.x', 'https://www.ncbi.nlm.nih.gov/pubmed/1801561', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma-globulin+treatment+in+Kawasaki+disease&author=K+Harada&publication_year=1991&hl=en']",1801561,https://doi.org/10.1111/j.1442-200X.1991.tb02612.x, Okuni 1987A {published data only}  ,included,CD014884-bbs2-0021,,16215725,,,208,,,1801561
CD014884-bib-0040,"Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T. ",Intravenous gamma globulin therapy in Kawasaki disease - trial of low dose gammaglobulin,,1987,,    ,['citation-other']," Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T. Intravenous gamma globulin therapy in Kawasaki disease - trial of low dose gammaglobulin. Kawasaki Disease1987:433-9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma+globulin+therapy+in+Kawasaki+disease+-+trial+of+low+dose+gammaglobulin&author=M+Okuni&author=K+Harada&author=H+Yamaguchi&author=H+Yanagawa&author=T+Sonobe&author=T+Kawasaki&publication_year=1987&hl=en']",,, Okuni 1987A {published data only}  ,included,CD014884-bbs2-0021,,,,,,,,
CD014884-bib-0041,Harada K. ,Intravenous gamma-globulin treatment in Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1991,33,    ,['citation-journal'], Harada K. Intravenous gamma-globulin treatment in Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1991;33(6):805-10. CENTRAL    Link to article     PubMed     Google Scholar     ,"['', 'https://doi.org/10.1111/j.1442-200X.1991.tb02612.x', 'https://www.ncbi.nlm.nih.gov/pubmed/1801561', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma-globulin+treatment+in+Kawasaki+disease&author=K+Harada&publication_year=1991&hl=en']",1801561,https://doi.org/10.1111/j.1442-200X.1991.tb02612.x, Okuni 1987B {published data only}  ,included,CD014884-bbs2-0022,,16215725,,,208,,,1801561
CD014884-bib-0042,"Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T. ",Intravenous gamma globulin therapy in Kawasaki disease - trial of low dose gammaglobulin,,1987,,    ,['citation-other']," Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T. Intravenous gamma globulin therapy in Kawasaki disease - trial of low dose gammaglobulin. Kawasaki Disease1987:433-9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma+globulin+therapy+in+Kawasaki+disease+-+trial+of+low+dose+gammaglobulin&author=M+Okuni&author=K+Harada&author=H+Yamaguchi&author=H+Yanagawa&author=T+Sonobe&author=T+Kawasaki&publication_year=1987&hl=en']",,, Okuni 1987B {published data only}  ,included,CD014884-bbs2-0022,,,,,,,,
CD014884-bib-0043,"Onouchi Z, Isogai Y, Yanagisawa M, Yamanouchi T, Matsuda H, Morita T, et al. ",Multicenter randomized controlled study of intravenous immunoglobulin in Kawasaki disease, Journal of the Japanese Pediatric Society ,1988,92,    ,['citation-journal']," Onouchi Z, Isogai Y, Yanagisawa M, Yamanouchi T, Matsuda H, Morita T, et al. Multicenter randomized controlled study of intravenous immunoglobulin in Kawasaki disease.  Journal of the Japanese Pediatric Society 1988;92(11):2367-76. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Multicenter+randomized+controlled+study+of+intravenous+immunoglobulin+in+Kawasaki+disease+&author=Z+Onouchi&author=Y+Isogai&author=M+Yanagisawa&author=T+Yamanouchi&author=H+Matsuda&author=T+Morita&publication_year=1988&hl=en']",,, Onouchi 1988 {published data only}  ,included,CD014884-bbs2-0023,,,,,,,,
CD014884-bib-0044,"Onouchi Z, Yanagisawa M, Hirayama T, Kiyosawa N, Matsuda H, Nakashima M. ",Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1995,37,    ,['citation-journal']," Onouchi Z, Yanagisawa M, Hirayama T, Kiyosawa N, Matsuda H, Nakashima M. Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1995;37(1):40-6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1442-200X.1995.tb03683.x', 'https://www.ncbi.nlm.nih.gov/pubmed/7754764', 'https://scholar.google.com/scholar_lookup?title=Optimal+dosage+and+differences+in+therapeutic+efficacy+of+IGIV+in+Kawasaki+disease&author=Z+Onouchi&author=M+Yanagisawa&author=T+Hirayama&author=N+Kiyosawa&author=H+Matsuda&author=M+Nakashima&publication_year=1995&hl=en']",7754764,https://doi.org/10.1111/j.1442-200X.1995.tb03683.x, Onouchi 1988 {published data only}  ,included,CD014884-bbs2-0023,,7754764,7754764,7754764,6,,,7754764
CD014884-bib-0045,"Onouchi Z, Yanagisawa M, Hirayama T, Kiyosawa N, Matsuda H, Nakashima M. ",Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1995,37,    ,['citation-journal']," Onouchi Z, Yanagisawa M, Hirayama T, Kiyosawa N, Matsuda H, Nakashima M. Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1995;37(1):40-6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1442-200X.1995.tb03683.x', 'https://www.ncbi.nlm.nih.gov/pubmed/7754764', 'https://scholar.google.com/scholar_lookup?title=Optimal+dosage+and+differences+in+therapeutic+efficacy+of+IGIV+in+Kawasaki+disease&author=Z+Onouchi&author=M+Yanagisawa&author=T+Hirayama&author=N+Kiyosawa&author=H+Matsuda&author=M+Nakashima&publication_year=1995&hl=en']",7754764,https://doi.org/10.1111/j.1442-200X.1995.tb03683.x, Onouchi 1992 {published data only}  ,included,CD014884-bbs2-0024,,7754764,7754764,7754764,6,,,7754764
CD014884-bib-0046,"Onouchi Z, Yanagisawa M, Shiraishi H, Hirayama T, Katsube Y, Kiyosawa N, et al. ",Multi-centre randomized controlled study of intravenous immunoglobulin G (C-425) for Kawasaki disease, Journal of the Japanese Pediatric Society ,1992,96,    ,['citation-journal']," Onouchi Z, Yanagisawa M, Shiraishi H, Hirayama T, Katsube Y, Kiyosawa N, et al. Multi-centre randomized controlled study of intravenous immunoglobulin G (C-425) for Kawasaki disease.  Journal of the Japanese Pediatric Society 1992;96(12):2669-79. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Multi-centre+randomized+controlled+study+of+intravenous+immunoglobulin+G+(C-425)+for+Kawasaki+disease+&author=Z+Onouchi&author=M+Yanagisawa&author=H+Shiraishi&author=T+Hirayama&author=Y+Katsube&author=N+Kiyosawa&publication_year=1992&hl=en']",,, Onouchi 1992 {published data only}  ,included,CD014884-bbs2-0024,,,,,,,,
CD014884-bib-0047,"Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, et al. ",Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study, Zhonghua er ke za zhi ,2006,44,    ,['citation-journal']," Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, et al. Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study.  Zhonghua er ke za zhi 2006;44(12):891-5. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/17254453', 'https://scholar.google.com/scholar_lookup?title=Therapeutic+effectiveness+of+intravenous+immunoglobulin+at+1+g/kg+and+2+g/kg+on+Kawasaki+disease:+a+comparative+and+follow-up+study+&author=LJ+Qin&author=HW+Wang&author=XF+Hu&author=QJ+Liu&author=H+Shi&author=YX+Wei&publication_year=2006&hl=en']",17254453,, Qin 2006 {published data only}  ,included,CD014884-bbs2-0025,,,,,,,,17254453
CD014884-bib-0048,"Ozawa S, Sakata K, Hamaoka K. ",Randomized-prospective study of a single infusion of 1g/kg gammaglobulin for reducing a total dose of gammaglobulin in Kawasaki disease treatment, Pediatric Research ,2003,53,    ,['citation-journal']," Ozawa S, Sakata K, Hamaoka K. Randomized-prospective study of a single infusion of 1g/kg gammaglobulin for reducing a total dose of gammaglobulin in Kawasaki disease treatment.  Pediatric Research 2003;53:181. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1203/00006450-200301000-00163', 'https://scholar.google.com/scholar_lookup?title=Randomized-prospective+study+of+a+single+infusion+of+1g/kg+gammaglobulin+for+reducing+a+total+dose+of+gammaglobulin+in+Kawasaki+disease+treatment+&author=S+Ozawa&author=K+Sakata&author=K+Hamaoka&publication_year=2003&hl=en']",,https://doi.org/10.1203/00006450-200301000-00163, Sakata 2007 {published data only}  ,included,CD014884-bbs2-0026,,,,,1,https://www.nature.com/articles/pr2003163.pdf,,
CD014884-bib-0049,"Sakata K, Hamaoka K, Ozawa SI, Niboshi A, Yoshihara T, Nishiki T, et al. ",A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease, European Journal of Pediatrics ,2007,166,    ,['citation-journal']," Sakata K, Hamaoka K, Ozawa SI, Niboshi A, Yoshihara T, Nishiki T, et al. A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease.  European Journal of Pediatrics 2007;166(6):565-71. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s00431-006-0280-3', 'https://www.ncbi.nlm.nih.gov/pubmed/17103193', 'https://scholar.google.com/scholar_lookup?title=A+randomized+prospective+study+on+the+use+of+2+g-IVIG+or+1+g-IVIG+as+therapy+for+Kawasaki+disease+&author=K+Sakata&author=K+Hamaoka&author=SI+Ozawa&author=A+Niboshi&author=T+Yoshihara&author=T+Nishiki&publication_year=2007&hl=en']",17103193,https://doi.org/10.1007/s00431-006-0280-3, Sakata 2007 {published data only}  ,included,CD014884-bbs2-0026,,,,17103193,21,,,17103193
CD014884-bib-0050,"Sato N, Sugimura T, Akagi T, Inoue O, Ono E, Kato H. ",Selective gammaglobulin treatment in Kawasaki disease: single 2 g/kg or 400 mg/kg/day for 5 days?,,1995,,    ,['citation-other']," Sato N, Sugimura T, Akagi T, Inoue O, Ono E, Kato H. Selective gammaglobulin treatment in Kawasaki disease: single 2 g/kg or 400 mg/kg/day for 5 days?Kawasaki Disease1995:332-8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Selective+gammaglobulin+treatment+in+Kawasaki+disease:+single+2+g/kg+or+400+mg/kg/day+for+5+days?+&author=N+Sato&author=T+Sugimura&author=T+Akagi&author=O+Inoue&author=E+Ono&author=H+Kato&publication_year=1995&hl=en']",,, Sato 1995 {published data only}  ,included,CD014884-bbs2-0027,,,,,,,,
CD014884-bib-0051,"Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, et al. ",Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness, Pediatrics International ,1999,41,    ,['citation-journal']," Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, et al. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.  Pediatrics International 1999;41(1):1-7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1442-200X.1999.t01-1-01014.x', 'https://www.ncbi.nlm.nih.gov/pubmed/10200128', 'https://scholar.google.com/scholar_lookup?title=Selective+high+dose+gamma-globulin+treatment+in+Kawasaki+disease:+assessment+of+clinical+aspects+and+cost+effectiveness+&author=N+Sato&author=T+Sugimura&author=T+Akagi&author=R+Yamakawa&author=K+Hashino&author=G+Eto&publication_year=1999&hl=en']",10200128,https://doi.org/10.1046/j.1442-200X.1999.t01-1-01014.x, Sato 1995 {published data only}  ,included,CD014884-bbs2-0027,,,10200128,,,,,10200128
CD014884-bib-0052,ChiCTR-EOC-17013266. ,The mechanism of coronary artery lesions and effect of treatment in children with Kawasaki disease: a clinical cohort study,,,,   ,['citation-other'], ChiCTR-EOC-17013266. The mechanism of coronary artery lesions and effect of treatment in children with Kawasaki disease: a clinical cohort study. chictr.org.cn/showproj.aspx?proj=22637 (first received 11 June 2017). CENTRAL    ,[''],,, Wang 2020 {published data only}  ,included,CD014884-bbs2-0028,,33557870,,,,,,33557870
CD014884-bib-0053,"Wang Z, Wang Y, Li W, Xie X, Liu P, Zhang X, et al. ",Methylprednisolone pulse therapy or additional IVIG for patients with IVIG-resistant Kawasaki disease, Journal of Immunology Research ,2020,2020,    ,['citation-journal']," Wang Z, Wang Y, Li W, Xie X, Liu P, Zhang X, et al. Methylprednisolone pulse therapy or additional IVIG for patients with IVIG-resistant Kawasaki disease.  Journal of Immunology Research 2020;2020:4175821. CENTRAL [DOI: 10.1155/2020/4175821]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1155/2020/4175821', 'https://www.ncbi.nlm.nih.gov/pubmed/33299898', 'https://scholar.google.com/scholar_lookup?title=Methylprednisolone+pulse+therapy+or+additional+IVIG+for+patients+with+IVIG-resistant+Kawasaki+disease+&author=Z+Wang&author=Y+Wang&author=W+Li&author=X+Xie&author=P+Liu&author=X+Zhang&publication_year=2020&hl=en']",33299898,https://doi.org/10.1155/2020/4175821, Wang 2020 {published data only}  ,included,CD014884-bbs2-0028,,,,33299898,18,https://downloads.hindawi.com/journals/jir/2020/4175821.pdf,,33299898
CD014884-bib-0054,"Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. ",High-dose intravenous gammaglobulin treatment of Kawasaki disease, Progress in Medicine ,1990,10,    ,['citation-journal']," Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. High-dose intravenous gammaglobulin treatment of Kawasaki disease.  Progress in Medicine 1990;10:29-38. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=High-dose+intravenous+gammaglobulin+treatment+of+Kawasaki+disease&author=H+Ogino&author=M+Ogawa&author=Y+Harima&author=S+Kono&author=H+Ohkuni&author=M+Nishida&publication_year=1990&hl=en']",,, Yabiku 1989 {published data only}  ,included,CD014884-bbs2-0029,,,,,,,,
CD014884-bib-0055,"Yabiku M, Kojima S, Ogawa M, Ogino H, Harima Y, Kono S, et al. ",High dose gammaglobulin therapy for Kawasaki disease, Journal of the Japanese Pediatric Society ,1989,93,    ,['citation-journal']," Yabiku M, Kojima S, Ogawa M, Ogino H, Harima Y, Kono S, et al. High dose gammaglobulin therapy for Kawasaki disease.  Journal of the Japanese Pediatric Society 1989;93(12):2721-31. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=High+dose+gammaglobulin+therapy+for+Kawasaki+disease&author=M+Yabiku&author=S+Kojima&author=M+Ogawa&author=H+Ogino&author=Y+Harima&author=S+Kono&publication_year=1989&hl=en']",,, Yabiku 1989 {published data only}  ,included,CD014884-bbs2-0029,,,,,,,,
CD014884-bib-0056,"Youn Y, Kim J, Hong YM, Sohn S. ",Infliximab as the first retreatment in patients with Kawasaki disease resistant to initial intravenous immunoglobulin, Pediatric Infectious Disease Journal ,2016,35,    ,['citation-journal']," Youn Y, Kim J, Hong YM, Sohn S. Infliximab as the first retreatment in patients with Kawasaki disease resistant to initial intravenous immunoglobulin.  Pediatric Infectious Disease Journal 2016;35(4):457-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/INF.0000000000001039', 'https://www.ncbi.nlm.nih.gov/pubmed/26673981', 'https://scholar.google.com/scholar_lookup?title=Infliximab+as+the+first+retreatment+in+patients+with+Kawasaki+disease+resistant+to+initial+intravenous+immunoglobulin+&author=Y+Youn&author=J+Kim&author=YM+Hong&author=S+Sohn&publication_year=2016&hl=en']",26673981,https://doi.org/10.1097/INF.0000000000001039, Youn 2016 {published data only}  ,included,CD014884-bbs2-0030,,,,26673981,42,,,26673981
CD014884-bib-0057,Yuan Y. ,Analysis of recent effects for corticosteroid in treating Kawasaki disease, Chinese Journal of Practical Paediatrics ,2000,15,    ,['citation-journal'], Yuan Y. Analysis of recent effects for corticosteroid in treating Kawasaki disease.  Chinese Journal of Practical Paediatrics 2000;15:49. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Analysis+of+recent+effects+for+corticosteroid+in+treating+Kawasaki+disease&author=Y+Yuan&publication_year=2000&hl=en']",,, Yuan 2000 {published data only}  ,included,CD014884-bbs2-0031,,,,,,,,
CD014884-bib-0058,ChiCTR2000035163. ,A multicenter clinical trial of a new individualized treatment opinion for Kawasaki disease,,,,   ,['citation-other'], ChiCTR2000035163. A multicenter clinical trial of a new individualized treatment opinion for Kawasaki disease. chictr.org.cn/showprojen.aspx?proj=57061 (first received 2 August 2020). CENTRAL    ,[''],,, ChiCTR2000035163 {published data only}  ,excluded,CD014884-bbs2-0032, Ongoing study to investigate KD treatment in participants either IVIGresistant or predicted to be IVIGresistant. IVIG not the differentiating intervention  ,,,,,,,
CD014884-bib-0059,"Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al. ","Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial", Lancet ,2019,393,    ,['citation-journal']," Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.  Lancet 2019;393(10176):1128-37. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/30853151', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+primary+treatment+with+immunoglobulin+plus+ciclosporin+for+prevention+of+coronary+artery+abnormalities+in+patients+with+Kawasaki+disease+predicted+to+be+at+increased+risk+of+non-response+to+intravenous+immunoglobulin+(KAICA):+a+randomised+controlled,+open-label,+blinded-endpoints,+phase+3+trial+&author=H+Hamada&author=H+Suzuki&author=Y+Onouchi&author=R+Ebata&author=M+Terai&author=S+Fuse&publication_year=2019&hl=en']",30853151,, Hamada 2019 {published data only}  ,excluded,CD014884-bbs2-0033, Study compared IVIG plus ciclosporin versus IVIG alone in people predicted to be at higher risk for IVIG resistance. IVIG not the differentiating intervention  ,,30853151,,,,,30853151
CD014884-bib-0060,"Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al. ","Efficacy of primary treatment with immunoglobulin plus cyclosporine for prevention of coronary artery abnormalities in Kawasaki disease patients predicted to be at increased risk of IVIG non-response (KAICA study): a controlled, phase 3, randomised, open-label, blinded-endpoints trial", Rheumatology ,2019,58,    ,['citation-journal']," Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al. Efficacy of primary treatment with immunoglobulin plus cyclosporine for prevention of coronary artery abnormalities in Kawasaki disease patients predicted to be at increased risk of IVIG non-response (KAICA study): a controlled, phase 3, randomised, open-label, blinded-endpoints trial.  Rheumatology 2019;58(Suppl 2):kez063-031. CENTRAL [DOI: 10.1093/rheumatology/kez063.031]    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+primary+treatment+with+immunoglobulin+plus+cyclosporine+for+prevention+of+coronary+artery+abnormalities+in+Kawasaki+disease+patients+predicted+to+be+at+increased+risk+of+IVIG+non-response+(KAICA+study):+a+controlled,+phase+3,+randomised,+open-label,+blinded-endpoints+trial+&author=H+Hamada&author=H+Suzuki&author=Y+Onouchi&author=R+Ebata&author=M+Terai&author=S+Fuse&publication_year=2019&hl=en']",,, Hamada 2019 {published data only}  ,excluded,CD014884-bbs2-0033, Study compared IVIG plus ciclosporin versus IVIG alone in people predicted to be at higher risk for IVIG resistance. IVIG not the differentiating intervention  ,,,,,,,
CD014884-bib-0061,ISRCTN71987471. ,Corticosteroids plus standard of care treatment versus standard of care treatment alone to prevent heart complications in Kawasaki disease,,,,   ,['citation-other'], ISRCTN71987471. Corticosteroids plus standard of care treatment versus standard of care treatment alone to prevent heart complications in Kawasaki disease. isrctn.com/ISRCTN71987471 (first received 31 March 2020). CENTRAL    ,[''],,, ISRCTN71987471 {published data only}  ,excluded,CD014884-bbs2-0034, Participants randomised to corticosteroid or nothing after initial IVIG plus ASA treatment. ,36703139,,,,,,36703139
CD014884-bib-0062,JPRN-UMIN000014665. ,The investigation of the therapeutic efficacy of rapid intravenous immunoglobulin injection for acute phase Kawasaki disease,,,,   ,['citation-other'], JPRN-UMIN000014665. The investigation of the therapeutic efficacy of rapid intravenous immunoglobulin injection for acute phase Kawasaki disease. trialsearch.who.int/Trial2.aspx?TrialID=JPRN-UMIN000014665 (first received 30 October 2014). CENTRAL    ,[''],,, JPRNUMIN000014665 {published data only}  ,excluded,CD014884-bbs2-0035, Study compared fast versus slow injection of IVIG. ,,,,,,,
CD014884-bib-0063,"Lee HK, Kim DS, Noh GW, Lee KY. ",Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease, Yonsei Medical Journal ,1996,37,    ,['citation-journal']," Lee HK, Kim DS, Noh GW, Lee KY. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease.  Yonsei Medical Journal 1996;37(5):357-63. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.3349/ymj.1996.37.5.357', 'https://www.ncbi.nlm.nih.gov/pubmed/8997168', 'https://scholar.google.com/scholar_lookup?title=Effects+of+intravenous+immune+globulin+on+the+peripheral+lymphocyte+phenotypes+in+Kawasaki+disease+&author=HK+Lee&author=DS+Kim&author=GW+Noh&author=KY+Lee&publication_year=1996&hl=en']",8997168,https://doi.org/10.3349/ymj.1996.37.5.357, Lee 1996 {published data only}  ,excluded,CD014884-bbs2-0036," Study only reported surrogate outcomes (lymphocyte phenotype), so does not meet our inclusion criteria.  ",8997168,,8997168,16,http://synapse.koreamed.org/Synapse/Data/PDFData/0069YMJ/ymj-37-357.pdf,,8997168
CD014884-bib-0064,"Lin SY, He L, Xie LP, Wang Y, Lin YX, Cao YY, et al. ","Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial", Trials ,2021,22,    ,['citation-journal']," Lin SY, He L, Xie LP, Wang Y, Lin YX, Cao YY, et al. Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial.  Trials 2021;22(2):898. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/s13063-021-05807-3', 'https://www.ncbi.nlm.nih.gov/pubmed/34895290', 'https://scholar.google.com/scholar_lookup?title=Effects+of+immunoglobulin+plus+prednisolone+in+reducing+coronary+artery+lesions+in+patients+with+Kawasaki+disease:+study+protocol+for+a+phase+III+multicenter,+open-label,+blinded-endpoints+randomized+controlled+trial+&author=SY+Lin&author=L+He&author=LP+Xie&author=Y+Wang&author=YX+Lin&author=YY+Cao&publication_year=2021&hl=en']",34895290,https://doi.org/10.1186/s13063-021-05807-3, Lin 2021 {published data only}  ,excluded,CD014884-bbs2-0037, Study plans to evaluate the efficacy of IVIG plus ASA plus prednisolone compared to IVIG plus ASA in Chinese paediatric participants with KD.  ,,34895290,34895290,4,https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05807-3,,34895290
CD014884-bib-0065,"Muta H, Ishii M, Hirose A, Furui J, Sugahara Y, Himeno W, et al. ",Randomized prospective controlled study of intravenous gamma-globulin products in treatment of Kawasaki disease, Journal of the Japan Pediatric Society ,2002,106,    ,['citation-journal']," Muta H, Ishii M, Hirose A, Furui J, Sugahara Y, Himeno W, et al. Randomized prospective controlled study of intravenous gamma-globulin products in treatment of Kawasaki disease.  Journal of the Japan Pediatric Society 2002;106(6):742-6. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Randomized+prospective+controlled+study+of+intravenous+gamma-globulin+products+in+treatment+of+Kawasaki+disease+&author=H+Muta&author=M+Ishii&author=A+Hirose&author=J+Furui&author=Y+Sugahara&author=W+Himeno&publication_year=2002&hl=en']",,, Muta 2002 {published data only}  ,excluded,CD014884-bbs2-0038," Study compared different types of IVIG, and dosage was determined by KD severity. ",,,,,,,
CD014884-bib-0066,"Muta H, Ishii M, Sugahara Y, Akagi T, Kato H. ",Randomized controlled study of intravenous gamma-globulin products in treatment of Kawasaki disease, Pediatric Research ,2003,53,    ,['citation-journal']," Muta H, Ishii M, Sugahara Y, Akagi T, Kato H. Randomized controlled study of intravenous gamma-globulin products in treatment of Kawasaki disease.  Pediatric Research 2003;53(1):181. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1203/00006450-200301000-00164', 'https://scholar.google.com/scholar_lookup?title=Randomized+controlled+study+of+intravenous+gamma-globulin+products+in+treatment+of+Kawasaki+disease+&author=H+Muta&author=M+Ishii&author=Y+Sugahara&author=T+Akagi&author=H+Kato&publication_year=2003&hl=en']",,https://doi.org/10.1203/00006450-200301000-00164, Muta 2002 {published data only}  ,excluded,CD014884-bbs2-0038," Study compared different types of IVIG, and dosage was determined by KD severity. ",,,,1,https://www.nature.com/articles/pr2003164.pdf,,
CD014884-bib-0067,"Nanishi E, Nishio H, Takada H, Yamamura K, Fukazawa M, Furuno K, et al. ","Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease: a phase 2, open-label, randomized control study", Journal of the American Heart Association ,2017,6,    ,['citation-journal']," Nanishi E, Nishio H, Takada H, Yamamura K, Fukazawa M, Furuno K, et al. Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease: a phase 2, open-label, randomized control study.  Journal of the American Heart Association 2017;6(7):e005370. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/JAHA.116.005370', 'https://www.ncbi.nlm.nih.gov/pubmed/28684643', 'https://scholar.google.com/scholar_lookup?title=Clarithromycin+plus+intravenous+immunoglobulin+therapy+can+reduce+the+relapse+rate+of+Kawasaki+disease:+a+phase+2,+open-label,+randomized+control+study+&author=E+Nanishi&author=H+Nishio&author=H+Takada&author=K+Yamamura&author=M+Fukazawa&author=K+Furuno&publication_year=2017&hl=en']",28684643,https://doi.org/10.1161/JAHA.116.005370, Nanishi 2017 {published data only}  ,excluded,CD014884-bbs2-0039, Study compared IVIG with IVIG plus clarithromycin. ,,28684643,28684643,7,https://doi.org/10.1161/jaha.116.005370,,28684643
CD014884-bib-0068,NCT02298062. ,"Infliximab for Kawasaki disease patients resistant to IVIG: a multicentre, prospective, randomised trial",,,,   ,['citation-other']," NCT02298062. Infliximab for Kawasaki disease patients resistant to IVIG: a multicentre, prospective, randomised trial. clinicaltrials.gov/ct2/show/NCT02298062 (first received 21 November 2014). CENTRAL    ",[''],,, NCT02298062 {published data only}  ,excluded,CD014884-bbs2-0040," Clinical trial report states completed September 2015, but no published report identified.We contacted the study investigators to request data (Fang Liu, Professor, Fudan University, [emailprotected]; January 2022). They replied to say that study was not completed due to limited participants and COVID19.  ",,,,,,,
CD014884-bib-0069,"Portman MA, Dahdah N, Olson AK, Slee A, Choueiter N, Altman C. ","Multicenter, randomized, double-blind trial of etanercept in acute Kawasaki disease", Circulation ,2017,136,    ,['citation-journal']," Portman MA, Dahdah N, Olson AK, Slee A, Choueiter N, Altman C. Multicenter, randomized, double-blind trial of etanercept in acute Kawasaki disease.  Circulation 2017;136:A15447. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Multicenter,+randomized,+double-blind+trial+of+etanercept+in+acute+Kawasaki+disease&author=MA+Portman&author=N+Dahdah&author=AK+Olson&author=A+Slee&author=N+Choueiter&author=C+Altman&publication_year=2017&hl=en']",,, Portman 2019 {published data only}  ,excluded,CD014884-bbs2-0041, Study randomised participants to either etanercept or placebo after initial dose of IVIG.  ,31048415,,,,,,31048415
CD014884-bib-0070,"Portman MA, Dahdah NS, Slee A, Olson AK, Choueiter NF, Soriano BD, et al. ",Etanercept with IVIg for acute Kawasaki disease: a randomized controlled trial, Pediatrics ,2019,143,    ,['citation-journal']," Portman MA, Dahdah NS, Slee A, Olson AK, Choueiter NF, Soriano BD, et al. Etanercept with IVIg for acute Kawasaki disease: a randomized controlled trial.  Pediatrics 2019;143:6. CENTRAL [DOI: 10.1542/peds.2018-3675]    Link to article     Google Scholar     ","['', 'https://doi.org/10.1542/peds.2018-3675', 'https://scholar.google.com/scholar_lookup?title=Etanercept+with+IVIg+for+acute+Kawasaki+disease:+a+randomized+controlled+trial&author=MA+Portman&author=NS+Dahdah&author=A+Slee&author=AK+Olson&author=NF+Choueiter&author=BD+Soriano&publication_year=2019&hl=en']",,https://doi.org/10.1542/peds.2018-3675, Portman 2019 {published data only}  ,excluded,CD014884-bbs2-0041, Study randomised participants to either etanercept or placebo after initial dose of IVIG.  ,,,31048415,62,https://pediatrics.aappublications.org/content/pediatrics/143/6/e20183675.full.pdf,,31048415
CD014884-bib-0071,"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al. ","Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial", Lancet ,2012,379,    ,['citation-journal']," Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.  Lancet 2012;379(9826):1613-20. CENTRAL [DOI: 10.1016/S0140-6736(11)61930-2]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(11)61930-2', 'https://www.ncbi.nlm.nih.gov/pubmed/22405251', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+immunoglobulin+plus+prednisolone+for+prevention+of+coronary+artery+abnormalities+in+severe+Kawasaki+disease+(RAISE+study):+a+randomised,+open-label,+blinded-endpoints+trial+&author=T+Kobayashi&author=T+Saji&author=T+Otani&author=K+Takeuchi&author=T+Nakamura&author=H+Arakawa&publication_year=2012&hl=en']",22405251,https://doi.org/10.1016/S0140-6736(11)61930-2, RAISE 2012 {published data only}  ,excluded,CD014884-bbs2-0042, Study compared IVIG plus ASA versus IVIG plus prednisolone. ,,,22405251,584,,,22405251
CD014884-bib-0072,"Sanati F, Bagheri M, Eslami S, Khalooei A. ",Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm, Annals of Pediatric Cardiology ,2021,14,    ,['citation-journal']," Sanati F, Bagheri M, Eslami S, Khalooei A. Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm.  Annals of Pediatric Cardiology 2021;14(2):146-51. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.4103/apc.APC_206_20', 'https://www.ncbi.nlm.nih.gov/pubmed/34103852', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+high-dose+aspirin+elimination+in+the+treatment+of+Kawasaki+disease+in+the+incidence+of+coronary+artery+aneurysm+&author=F+Sanati&author=M+Bagheri&author=S+Eslami&author=A+Khalooei&publication_year=2021&hl=en']",34103852,https://doi.org/10.4103/apc.APC_206_20, Sanati 2021 {published data only}  ,excluded,CD014884-bbs2-0043, Study compared IVIG versus IVIG plus ASA. ,34103852,34103852,34103852,6,https://doi.org/10.4103/apc.apc_206_20,,34103852
CD014884-bib-0073,"Seki M, Minami T, Oka K, Yokomizo A, Matsubara D, Sato T, et al. ",Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial, Pediatric Rheumatology ,2021,19,    ,['citation-journal']," Seki M, Minami T, Oka K, Yokomizo A, Matsubara D, Sato T, et al. Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial.  Pediatric Rheumatology 2021;19(1):107. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/34217297', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+associated+with+the+infusion+speed+of+intravenous+immunoglobulin+for+the+treatment+of+Kawasaki+disease:+a+randomized+controlled+trial+&author=M+Seki&author=T+Minami&author=K+Oka&author=A+Yokomizo&author=D+Matsubara&author=T+Sato&publication_year=2021&hl=en']",34217297,, Seki 2021 {published data only}  ,excluded,CD014884-bbs2-0044, Study compared different speeds of IVIG infusion. ,,34217297,,,,,34217297
CD014884-bib-0100,"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y. ","Epidemiology, treatments and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018", Journal of Pediatrics ,2020,225,    ,['citation-journal']," Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y. Epidemiology, treatments and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018.  Journal of Pediatrics 2020;225:23-9.e2. [DOI: 10.1016/j.jpeds.2020.05.034]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jpeds.2020.05.034', 'https://www.ncbi.nlm.nih.gov/pubmed/32454114', 'https://scholar.google.com/scholar_lookup?title=Epidemiology,+treatments+and+cardiac+complications+in+patients+with+Kawasaki+disease:+the+nationwide+survey+in+Japan,+2017-2018+&author=R+Ae&author=N+Makino&author=K+Kosami&author=M+Kuwabara&author=Y+Matsubara&author=Y+Nakamura&publication_year=2020&hl=en']",32454114,https://doi.org/10.1016/j.jpeds.2020.05.034, Ae 2020 ,additional,CD014884-bbs2-0070,,32454114,32454114,32454114,157,,,32454114
CD014884-bib-0101,"Ae R, Yashiro M, Matsubara Y, Osami M, Makino S, Nakamura Y. ",Results of the 26th nationwide survey of Kawasaki disease in Japan,,,,. jichi.ac.jp/dph/wp-dph/wp-content/uploads/2022/04/a19b047d4b9e6fbb84b6b187236779c8.pdf.   ,['citation-other']," Ae R, Yashiro M, Matsubara Y, Osami M, Makino S, Nakamura Y. Results of the 26th nationwide survey of Kawasaki disease in Japan. jichi.ac.jp/dph/wp-dph/wp-content/uploads/2022/04/a19b047d4b9e6fbb84b6b187236779c8.pdf.    ",[],,, Ae 2021 ,additional,CD014884-bbs2-0071,,,,,,,,
CD014884-bib-0102,"Ashouri N, Takahashi M, Dorey F, Mason W. ",Risk factors for non response to therapy in Kawasaki disease, Journal of Pediatrics ,2008,153,    ,['citation-journal']," Ashouri N, Takahashi M, Dorey F, Mason W. Risk factors for non response to therapy in Kawasaki disease.  Journal of Pediatrics 2008;153(3):3.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jpeds.2008.03.014', 'https://www.ncbi.nlm.nih.gov/pubmed/18571522', 'https://scholar.google.com/scholar_lookup?title=Risk+factors+for+non+response+to+therapy+in+Kawasaki+disease&author=N+Ashouri&author=M+Takahashi&author=F+Dorey&author=W+Mason&publication_year=2008&hl=en']",18571522,https://doi.org/10.1016/j.jpeds.2008.03.014, Ashouri 2008 ,additional,CD014884-bbs2-0072,,,,18534243,60,,,18571522
CD014884-bib-0103,"Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. ",Grading quality of evidence and strength of recommendations, BMJ ,2004,328,    ,['citation-journal']," Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations.  BMJ 2004;328(7454):1490-4.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/15205295', 'https://scholar.google.com/scholar_lookup?title=Grading+quality+of+evidence+and+strength+of+recommendations&author=D+Atkins&author=D+Best&author=PA+Briss&author=M+Eccles&author=Y+Falck-Ytter&author=S+Flottorp&publication_year=2004&hl=en']",15205295,, Atkins 2004 ,additional,CD014884-bbs2-0073,,,,,,,,15205295
CD014884-bib-0104,"Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Kawasaki Disease Research Committee. ",Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition), Pediatrics International ,2005,47,    ,['citation-journal']," Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).  Pediatrics International 2005;47(2):232-4.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1442-200x.2005.02033.x', 'https://www.ncbi.nlm.nih.gov/pubmed/15771703', 'https://scholar.google.com/scholar_lookup?title=Revision+of+diagnostic+guidelines+for+Kawasaki+disease+(the+5th+revised+edition)&author=M+Ayusawa&author=T+Sonobe&author=S+Uemura&author=S+Ogawa&author=Y+Nakamura&author=N+Kiyosawa&publication_year=2005&hl=en']",15771703,https://doi.org/10.1111/j.1442-200x.2005.02033.x, Ayusawa 2005 ,additional,CD014884-bbs2-0074,,15771703,,15771703,503,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1442-200x.2005.02033.x,,15771703
CD014884-bib-0105,"Baumer JH, Love S, Gupta A, Haines L, Maconochie IK, Dua JS. ",Salicylate for the treatment of Kawasaki disease in children, Cochrane Database of Systematic Reviews ,2006,,    ,['citation-journal']," Baumer JH, Love S, Gupta A, Haines L, Maconochie IK, Dua JS. Salicylate for the treatment of Kawasaki disease in children.  Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD004175. [DOI: 10.1002/14651858.CD004175.pub2]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD004175.pub2', 'https://www.ncbi.nlm.nih.gov/pubmed/17054199', 'https://scholar.google.com/scholar_lookup?title=Salicylate+for+the+treatment+of+Kawasaki+disease+in+children&author=JH+Baumer&author=S+Love&author=A+Gupta&author=L+Haines&author=IK+Maconochie&author=JS+Dua&publication_year=2006&hl=en']",17054199,https://doi.org/10.1002/14651858.CD004175.pub2, Baumer 2006 ,additional,CD014884-bbs2-0075,,,,17054199,86,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765111,,17054199
CD014884-bib-0106,"Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. ",Sequelae of Kawasaki disease in adolescents and young adults, Journal of the American College of Cardiology ,1996,28,    ,['citation-journal']," Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults.  Journal of the American College of Cardiology 1996;28:2537.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/0735-1097(96)00099-X', 'https://www.ncbi.nlm.nih.gov/pubmed/8752822', 'https://scholar.google.com/scholar_lookup?title=Sequelae+of+Kawasaki+disease+in+adolescents+and+young+adults&author=JC+Burns&author=H+Shike&author=JB+Gordon&author=A+Malhotra&author=M+Schoenwetter&author=T+Kawasaki&publication_year=1996&hl=en']",8752822,https://doi.org/10.1016/0735-1097(96)00099-X, Burns 1996 ,additional,CD014884-bbs2-0076,,,,8752822,334,https://doi.org/10.1016/0735-1097(96)00099-x,,8752822
CD014884-bib-0107,"Burns JC, Franco A. ",The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease, Expert Reviews of Clinical Immunology ,2015,11,    ,['citation-journal']," Burns JC, Franco A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.  Expert Reviews of Clinical Immunology 2015;11:81925. [DOI: 10.1586/1744666X.2015.1044980]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1586/1744666X.2015.1044980', 'https://www.ncbi.nlm.nih.gov/pubmed/26099344', 'https://scholar.google.com/scholar_lookup?title=The+immunomodulatory+effects+of+intravenous+immunoglobulin+therapy+in+Kawasaki+disease&author=JC+Burns&author=A+Franco&publication_year=2015&hl=en']",26099344,https://doi.org/10.1586/1744666X.2015.1044980, Burns 2015 ,additional,CD014884-bbs2-0077,,34953816,,26099344,123,https://europepmc.org/articles/pmc4985263?pdf=render,,26099344
CD014884-bib-0108,ChiCTR-EOC-17013266. ,The mechanism of coronary artery lesions and effect of treatment in children with Kawasaki disease: a clinical cohort study,,,,. chictr.org.cn/showproj.aspx?proj=22637 (first received 11 June 2017).   ,['citation-other'], ChiCTR-EOC-17013266. The mechanism of coronary artery lesions and effect of treatment in children with Kawasaki disease: a clinical cohort study. chictr.org.cn/showproj.aspx?proj=22637 (first received 11 June 2017).    ,[],,, ChiCTREOC17013266 ,additional,CD014884-bbs2-0078,,33557870,,,,,,33557870
CD014884-bib-0109,,Covidence,,,,". Version accessed 15 June 2021. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.   ",['citation-other']," Covidence. Version accessed 15 June 2021. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.    ",[],,, Covidence [Computer program] ,additional,CD014884-bbs2-0079,,41699724,,,,,,41699724
CD014884-bib-0110,"Dallaire F, Dahdah N. ",New equations and a critical appraisal of coronary artery Z scores in healthy children, Journal of the American Society of Echocardiography ,2011,24,    ,['citation-journal']," Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children.  Journal of the American Society of Echocardiography 2011;24(1):60-74. [DOI: 10.1016/j.echo.2010.10.004] [PMID: 21074965]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.echo.2010.10.004', 'https://www.ncbi.nlm.nih.gov/pubmed/21074965', 'https://scholar.google.com/scholar_lookup?title=New+equations+and+a+critical+appraisal+of+coronary+artery+Z+scores+in+healthy+children&author=F+Dallaire&author=N+Dahdah&publication_year=2011&hl=en']",21074965,https://doi.org/10.1016/j.echo.2010.10.004, Dallaire 2010 ,additional,CD014884-bbs2-0080,,,,21074965,267,,,21074965
CD014884-bib-0111,"Daniels LB, Tjajadi MS, Walford HH, Jimenez-Fernandez S, Trofimenko V, Fick DB Jr, et al. ",Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia, Circulation ,2012,125,    ,['citation-journal']," Daniels LB, Tjajadi MS, Walford HH, Jimenez-Fernandez S, Trofimenko V, Fick DB Jr, et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.  Circulation 2012;125:244753. [DOI: 10.1161/CIRCULATIONAHA.111.082107]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1161/CIRCULATIONAHA.111.082107', 'https://www.ncbi.nlm.nih.gov/pubmed/22595319', 'https://scholar.google.com/scholar_lookup?title=Prevalence+of+Kawasaki+disease+in+young+adults+with+suspected+myocardial+ischemia&author=LB+Daniels&author=MS+Tjajadi&author=HH+Walford&author=S+Jimenez-Fernandez&author=V+Trofimenko&publication_year=2012&hl=en']",22595319,https://doi.org/10.1161/CIRCULATIONAHA.111.082107, Daniels 2012 ,additional,CD014884-bbs2-0081,,,,,,,,22595319
CD014884-bib-0112,"Deeks JJ, Higgins JP, Altman DG, editor(s). ","Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021",,,,. Available from training.cochrane.org/handbook/archive/v6.2.   ,['citation-other']," Deeks JJ, Higgins JP, Altman DG, editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.    ",[],,, Deeks 2021 ,additional,CD014884-bbs2-0082,,,,,,,,
CD014884-bib-0113,"de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, et al. ",European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative, Rheumatology (OXFORD) ,2019,58,    ,['citation-journal']," de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative.  Rheumatology (OXFORD) 2019;58(4):672-82.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/rheumatology/key344', 'https://www.ncbi.nlm.nih.gov/pubmed/30535127', 'https://scholar.google.com/scholar_lookup?title=European+consensus-based+recommendations+for+the+diagnosis+and+treatment+of+Kawasaki+disease+-+the+SHARE+initiative+&author=N+Graeff&author=N+Groot&author=S+Ozen&author=D+Eleftheriou&author=T+Avcin&author=B+Bader-Meunier&publication_year=2019&hl=en']",30535127,https://doi.org/10.1093/rheumatology/key344, de Graeff 2019 ,additional,CD014884-bbs2-0083,,,30535127,30535127,144,https://discovery.ucl.ac.uk/10072207/1/SHARE%20KD%20Recommendations%20-%20Rheumatology%20Manuscript%20-%20270618%20-%20Final.pdf,,30535127
CD014884-bib-0114,"Franco A, Shimizu C, Tremoulet AH, Burns JC. ",Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease, Autoimmunity ,2010,43,    ,['citation-journal']," Franco A, Shimizu C, Tremoulet AH, Burns JC. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease.  Autoimmunity 2010;43(4):31724. [DOI: 10.3109/08916930903405891]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3109/08916930903405891', 'https://www.ncbi.nlm.nih.gov/pubmed/20166878', 'https://scholar.google.com/scholar_lookup?title=Memory+T-cells+and+characterization+of+peripheral+T-cell+clones+in+acute+Kawasaki+disease+&author=A+Franco&author=C+Shimizu&author=AH+Tremoulet&author=JC+Burns&publication_year=2010&hl=en']",20166878,https://doi.org/10.3109/08916930903405891, Franco 2010 ,additional,CD014884-bbs2-0084,,20166878,20166878,20166878,69,https://europepmc.org/articles/pmc2871072?pdf=render,,20166878
CD014884-bib-0115,Gedalia A. ,Kawasaki disease: 40 years after the original report, Current Rheumatology Reports ,2007,9,    ,['citation-journal'], Gedalia A. Kawasaki disease: 40 years after the original report.  Current Rheumatology Reports 2007;9(4):33641.    Link to article     PubMed     Google Scholar     ,"['https://doi.org/10.1007/s11926-007-0053-7', 'https://www.ncbi.nlm.nih.gov/pubmed/17688844', 'https://scholar.google.com/scholar_lookup?title=Kawasaki+disease:+40+years+after+the+original+report&author=A+Gedalia&publication_year=2007&hl=en']",17688844,https://doi.org/10.1007/s11926-007-0053-7, Gedalia 2007 ,additional,CD014884-bbs2-0085,,17688844,,17688844,28,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089469,,17688844
CD014884-bib-0116,,GRADEpro GDT,,,,. Version accessed 6 November 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.   ,['citation-other'], GRADEpro GDT. Version accessed 6 November 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.    ,[],,, GRADEpro GDT [Computer program] ,additional,CD014884-bbs2-0086,,41626889,,,,,,41626889
CD014884-bib-0117,"Green J, Wardle AJ, Tulloh RM. ",Corticosteroids for the treatment of Kawasaki disease in children, Cochrane Database of Systematic Reviews ,2022,,    ,['citation-journal']," Green J, Wardle AJ, Tulloh RM. Corticosteroids for the treatment of Kawasaki disease in children.  Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No: CD011188. [DOI: 10.1002/14651858.CD011188.pub3]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Corticosteroids+for+the+treatment+of+Kawasaki+disease+in+children&author=J+Green&author=AJ+Wardle&author=RM+Tulloh&publication_year=2022&hl=en'],,, Green 2022 ,additional,CD014884-bbs2-0087,,35622534,,,,,,35622534
CD014884-bib-0118,"Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al. ","Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial", Lancet ,2019,393,    ,['citation-journal']," Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.  Lancet 2019;393(10176):112837.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/30853151', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+primary+treatment+with+immunoglobulin+plus+ciclosporin+for+prevention+of+coronary+artery+abnormalities+in+patients+with+Kawasaki+disease+predicted+to+be+at+increased+risk+of+non-response+to+intravenous+immunoglobulin+(KAICA):+a+randomised+controlled,+open-label,+blinded-endpoints,+phase+3+trial+&author=H+Hamada&author=H+Suzuki&author=Y+Onouchi&author=R+Ebata&author=M+Terai&author=S+Fuse&publication_year=2019&hl=en']",30853151,, Hamada 2019 ,additional,CD014884-bbs2-0088,,,30853151,,,,,30853151
CD014884-bib-0119,Harada K. ,Intravenous gamma-globulin treatment in Kawasaki disease, Acta Paediatrica Japonica: Overseas edition ,1991,33,    ,['citation-journal'], Harada K. Intravenous gamma-globulin treatment in Kawasaki disease.  Acta Paediatrica Japonica: Overseas edition 1991;33(6):805-10.    Link to article     PubMed     Google Scholar     ,"['https://doi.org/10.1111/j.1442-200X.1991.tb02612.x', 'https://www.ncbi.nlm.nih.gov/pubmed/1801561', 'https://scholar.google.com/scholar_lookup?title=Intravenous+gamma-globulin+treatment+in+Kawasaki+disease&author=K+Harada&publication_year=1991&hl=en']",1801561,https://doi.org/10.1111/j.1442-200X.1991.tb02612.x, Harada 1991 ,additional,CD014884-bbs2-0089,,16215725,,,208,,,1801561
CD014884-bib-0120,"Hayasaka S, Nakamura Y, Yashiro M, Uehara R, Oki I, Tajimi M, et al. ",Analysis of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years, Journal of Epidemiology ,2003,13,    ,['citation-journal']," Hayasaka S, Nakamura Y, Yashiro M, Uehara R, Oki I, Tajimi M, et al. Analysis of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years.  Journal of Epidemiology 2003;13:24650.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.2188/jea.13.246', 'https://www.ncbi.nlm.nih.gov/pubmed/14604219', 'https://scholar.google.com/scholar_lookup?title=Analysis+of+fatal+cases+of+Kawasaki+disease+in+Japan+using+vital+statistical+data+over+27+years+&author=S+Hayasaka&author=Y+Nakamura&author=M+Yashiro&author=R+Uehara&author=I+Oki&author=M+Tajimi&publication_year=2003&hl=en']",14604219,https://doi.org/10.2188/jea.13.246, Hayasaka 2003 ,additional,CD014884-bbs2-0090,,,,14604219,19,https://www.jstage.jst.go.jp/article/jea1991/13/5/13_5_246/_pdf,,14604219
CD014884-bib-0121,"Higgins JP, Green S, editor(s). ","Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from training.cochrane.org/handbook/archive/v5.1/.   ,['citation-other']," Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.    ",[],,, Higgins 2011 ,additional,CD014884-bbs2-0091,,,,,,,,
CD014884-bib-0122,"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). ","Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021",,,,. Available from training.cochrane.org/handbook/archive/v6.2.   ,['citation-other']," Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.    ",[],,, Higgins 2021 ,additional,CD014884-bbs2-0092,,,,,,,,
CD014884-bib-0123,"Hokosaki T, Mori M, Nishizawa T, Nakamura T, Imagawa T, Iwamoto M, et al. ",Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease, Pediatrics International ,2012,54,    ,['citation-journal']," Hokosaki T, Mori M, Nishizawa T, Nakamura T, Imagawa T, Iwamoto M, et al. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease.  Pediatrics International 2012;54(1):99-103. [DOI: 10.1111/j.1442-200X.2011.03487.x]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1442-200X.2011.03487.x', 'https://www.ncbi.nlm.nih.gov/pubmed/22004042', 'https://scholar.google.com/scholar_lookup?title=Long-term+efficacy+of+plasma+exchange+treatment+for+refractory+Kawasaki+disease&author=T+Hokosaki&author=M+Mori&author=T+Nishizawa&author=T+Nakamura&author=T+Imagawa&author=M+Iwamoto&publication_year=2012&hl=en']",22004042,https://doi.org/10.1111/j.1442-200X.2011.03487.x, Hokosaki 2012 ,additional,CD014884-bbs2-0093,,,,22004042,65,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1442-200X.2011.03487.x,,22004042
CD014884-bib-0124,"Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, et al. ",Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii, Hawaii Medical Journal ,2010,69,    ,['citation-journal']," Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii.  Hawaii Medical Journal 2010;69:1947.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/20845285', 'https://scholar.google.com/scholar_lookup?title=Racial/ethnic+differences+in+the+incidence+of+Kawasaki+syndrome+among+children+in+Hawaii+&author=RC+Holman&author=KY+Christensen&author=ED+Belay&author=CA+Steiner&author=PV+Effler&author=J+Miyamura&publication_year=2010&hl=en']",20845285,, Holman 2010 ,additional,CD014884-bbs2-0094,,,20845285,,,,,20845285
CD014884-bib-0125,Research Committee on Kawasaki Disease. ,Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease,,,,. Tokyo: Japanese Ministry of Health and Welfare; 1984.   ,['citation-other'], Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo: Japanese Ministry of Health and Welfare; 1984.    ,[],,, JMHW 1984 ,additional,CD014884-bbs2-0095,,,,,,,,
CD014884-bib-0126,Kawasaki T. ,Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children, Arerugi ,1967,16,    ,['citation-journal'], Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children.  Arerugi 1967;16(3):178222.    PubMed     Google Scholar     ,"['https://www.ncbi.nlm.nih.gov/pubmed/6062087', 'https://scholar.google.com/scholar_lookup?title=Acute+febrile+mucocutaneous+syndrome+with+lymphoid+involvement+with+specific+desquamation+of+the+fingers+and+toes+in+children+&author=T+Kawasaki&publication_year=1967&hl=en']",6062087,, Kawasaki 1967 ,additional,CD014884-bbs2-0096,,6062087,6062087,,,,,6062087
CD014884-bib-0127,"Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K, Z Score Project Investigators. ",A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population, Journal of the American Society of Echocardiography ,2016,29,    ,['citation-journal']," Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K, Z Score Project Investigators. A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population.  Journal of the American Society of Echocardiography 2016;29(8):794-801.e29. [DOI: 10.1016/j.echo.2016.03.017] [PMID: 27288089]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.echo.2016.03.017', 'https://www.ncbi.nlm.nih.gov/pubmed/27288089', 'https://scholar.google.com/scholar_lookup?title=A+new+Z+score+curve+of+the+coronary+arterial+internal+diameter+using+the+lambda-mu-sigma+method+in+a+pediatric+population+&author=T+Kobayashi&author=S+Fuse&author=N+Sakamoto&author=M+Mikami&author=S+Ogawa&author=K+Hamaoka&publication_year=2016&hl=en']",27288089,https://doi.org/10.1016/j.echo.2016.03.017, Kobayashi 2016 ,additional,CD014884-bbs2-0097,,,,27288089,192,,,27288089
CD014884-bib-0128,"Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T, et al. ",Revision of diagnostic guidelines for Kawasaki disease (6th revised edition), Pediatrics International ,2020,62,    ,['citation-journal']," Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T, et al. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).  Pediatrics International 2020;62(10):1135-8. [DOI: 10.1111/ped.14326] [PMID: 33001522]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/ped.14326', 'https://www.ncbi.nlm.nih.gov/pubmed/33001522', 'https://scholar.google.com/scholar_lookup?title=Revision+of+diagnostic+guidelines+for+Kawasaki+disease+(6th+revised+edition)&author=T+Kobayashi&author=M+Ayusawa&author=H+Suzuki&author=J+Abe&author=S+Ito&author=T+Kato&publication_year=2020&hl=en']",33001522,https://doi.org/10.1111/ped.14326, Kobayashi 2020 ,additional,CD014884-bbs2-0098,,,,33001522,203,,,33001522
CD014884-bib-0129,"Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, et al. ",The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series, Autoimmunity Reviews ,2018,17,    ,['citation-journal']," Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, et al. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series.  Autoimmunity Reviews 2018;17(8):76874. [DOI: 10.1016/j.autrev.2018.01.024]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.autrev.2018.01.024', 'https://www.ncbi.nlm.nih.gov/pubmed/29885546', 'https://scholar.google.com/scholar_lookup?title=The+use+of+interleukin+1+receptor+antagonist+(anakinra)+in+Kawasaki+disease:+a+retrospective+cases+series+&author=I+Kone-Paut&author=R+Cimaz&author=J+Herberg&author=O+Bates&author=A+Carbasse&author=JP+Saulnier&publication_year=2018&hl=en']",29885546,https://doi.org/10.1016/j.autrev.2018.01.024, KonePaut 2018 ,additional,CD014884-bbs2-0099,,,,29885546,108,https://air.unimi.it/bitstream/2434/666625/4/The%20use%20of%20interleukin%201%20receptor%20antagonistARDEF.pdf,,29885546
CD014884-bib-0130,"Lee TJ, Kim KH, Chun JK, Kim DS. ",Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease, Yonsei Medical Journal ,2008,49,    ,['citation-journal']," Lee TJ, Kim KH, Chun JK, Kim DS. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.  Yonsei Medical Journal 2008;49(5):7148. [DOI: 10.3349/ymj.2008.49.5.714]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3349/ymj.2008.49.5.714', 'https://www.ncbi.nlm.nih.gov/pubmed/18972590', 'https://scholar.google.com/scholar_lookup?title=Low-dose+methotrexate+therapy+for+intravenous+immunoglobulin-resistant+Kawasaki+disease&author=TJ+Lee&author=KH+Kim&author=JK+Chun&author=DS+Kim&publication_year=2008&hl=en']",18972590,https://doi.org/10.3349/ymj.2008.49.5.714, Lee 2008 ,additional,CD014884-bbs2-0100,,18972590,,18972590,51,https://doi.org/10.3349/ymj.2008.49.5.714,,18972590
CD014884-bib-0131,"Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Marshall C, et al. ","Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022",,,,. Available from training.cochrane.org/handbook.   ,['citation-other']," Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Marshall C, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.    ",[],,, Lefebvre 2022 ,additional,CD014884-bbs2-0101,,,,,,,,
CD014884-bib-0132,"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. ",The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLOS Medicine ,2009,6,    ,['citation-journal']," Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.  PLOS Medicine 2009;6:e1000100.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1371/journal.pmed.1000100', 'https://www.ncbi.nlm.nih.gov/pubmed/19621070', 'https://scholar.google.com/scholar_lookup?title=The+PRISMA+statement+for+reporting+systematic+reviews+and+meta-analyses+of+studies+that+evaluate+health+care+interventions:+explanation+and+elaboration+&author=A+Liberati&author=DG+Altman&author=J+Tetzlaff&author=C+Mulrow&author=PC+Gotzsche&author=JP+Ioannidis&publication_year=2009&hl=en']",19621070,https://doi.org/10.1371/journal.pmed.1000100, Liberati 2009 ,additional,CD014884-bbs2-0102,,,19631507,19631507,36814,https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1000100&type=printable,,19621070
CD014884-bib-0133,"Maddox RA, Person MK, Lindsay JL, Baherling DL, Steiner CA, Schonberger LB, et al. ",Monitoring the occurrence of Kawasaki syndrome in the United States, Circulation ,2015,131,    ,['citation-journal']," Maddox RA, Person MK, Lindsay JL, Baherling DL, Steiner CA, Schonberger LB, et al. Monitoring the occurrence of Kawasaki syndrome in the United States.  Circulation 2015;131(Suppl 2):Abstract 0.03.    Link to article     Google Scholar     ","['https://doi.org/10.1161/circ.131.suppl_2.o03', 'https://scholar.google.com/scholar_lookup?title=Monitoring+the+occurrence+of+Kawasaki+syndrome+in+the+United+States&author=RA+Maddox&author=MK+Person&author=JL+Lindsay&author=DL+Baherling&author=CA+Steiner&author=LB+Schonberger&publication_year=2015&hl=en']",,https://doi.org/10.1161/circ.131.suppl_2.o03, Maddox 2015 ,additional,CD014884-bbs2-0103,,,,,4,,,
CD014884-bib-0134,"Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. ","Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey", Journal of Epidemiology ,2015,25,    ,['citation-journal']," Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.  Journal of Epidemiology 2015;25(3):23945.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.2188/jea.JE20140089', 'https://www.ncbi.nlm.nih.gov/pubmed/25716368', 'https://scholar.google.com/scholar_lookup?title=Descriptive+epidemiology+of+Kawasaki+disease+in+Japan,+2011-2012:+from+the+results+of+the+22nd+nationwide+survey+&author=N+Makino&author=Y+Nakamura&author=M+Yashiro&author=R+Ae&author=S+Tsuboi&author=Y+Aoyama&publication_year=2015&hl=en']",25716368,https://doi.org/10.2188/jea.JE20140089, Makino 2015 ,additional,CD014884-bbs2-0104,,,25716368,25716368,298,https://www.jstage.jst.go.jp/article/jea/25/3/25_JE20140089/_pdf,,25716368
CD014884-bib-0135,"Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, et al. ","The nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016", Pediatrics International ,2019,61,    ,['citation-journal']," Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, et al. The nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.  Pediatrics International 2019;61(4):397403. [DOI: 10.1111/ped.13809]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/ped.13809', 'https://www.ncbi.nlm.nih.gov/pubmed/30786118', 'https://scholar.google.com/scholar_lookup?title=The+nationwide+epidemiologic+survey+of+Kawasaki+disease+in+Japan,+2015-2016&author=N+Makino&author=Y+Nakamura&author=M+Yashiro&author=K+Kosami&author=Y+Matsubara&author=R+Ae&publication_year=2019&hl=en']",30786118,https://doi.org/10.1111/ped.13809, Makino 2019 ,additional,CD014884-bbs2-0105,,,,30786118,185,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ped.13809,,30786118
CD014884-bib-0136,"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, and Council on Epidemiology and Prevention, et al. ","Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association", Circulation ,2017,135,    ,['citation-journal']," McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, and Council on Epidemiology and Prevention, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association.  Circulation 2017;135(17):e927-99. [DOI: 10.1161/CIR.0000000000000484]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1161/CIR.0000000000000484', 'https://www.ncbi.nlm.nih.gov/pubmed/28356445', 'https://scholar.google.com/scholar_lookup?title=Diagnosis,+treatment,+and+long-term+management+of+Kawasaki+disease:+a+scientific+statement+for+health+professionals+from+the+American+Heart+Association+&author=BW+McCrindle&author=AH+Rowley&author=JW+Newburger&author=JC+Burns&author=AF+Bolger&author=M+Gewitz&publication_year=2017&hl=en']",28356445,https://doi.org/10.1161/CIR.0000000000000484, McCrindle 2017 ,additional,CD014884-bbs2-0106,,,,28356445,2683,https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000484,,28356445
CD014884-bib-0137,"Miura M, Ayusawa M, Fukazawa R, Hamada H, Ikeda S, Ito S, et al. ",Guidelines for medical treatment of acute Kawasaki disease (2020 revised version), Journal of Pediatric Cardiology and Cardiac Surgery ,2021,5,    ,['citation-journal']," Miura M, Ayusawa M, Fukazawa R, Hamada H, Ikeda S, Ito S, et al. Guidelines for medical treatment of acute Kawasaki disease (2020 revised version).  Journal of Pediatric Cardiology and Cardiac Surgery 2021;5(1):41-73. [DOI: 10.24509/jpccs.0501G1]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Guidelines+for+medical+treatment+of+acute+Kawasaki+disease+(2020+revised+version)&author=M+Miura&author=M+Ayusawa&author=R+Fukazawa&author=H+Hamada&author=S+Ikeda&author=S+Ito&publication_year=2021&hl=en'],,, Miura 2021 ,additional,CD014884-bbs2-0107,,,,,,,,
CD014884-bib-0138,"Mori M, Miyamae T, Imagawa T, Katakura S, Kimura K, Yokota S. ",Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease, Modern Rheumatology ,2004,14,    ,['citation-journal']," Mori M, Miyamae T, Imagawa T, Katakura S, Kimura K, Yokota S. Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease.  Modern Rheumatology 2004;14(5):3616. [DOI: 10.1007/s10165-004-0324-3]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3109/s10165-004-0324-3', 'https://www.ncbi.nlm.nih.gov/pubmed/17143694', 'https://scholar.google.com/scholar_lookup?title=Meta-analysis+of+the+results+of+intravenous+gamma+globulin+treatment+of+coronary+artery+lesions+in+Kawasaki+disease+&author=M+Mori&author=T+Miyamae&author=T+Imagawa&author=S+Katakura&author=K+Kimura&author=S+Yokota&publication_year=2004&hl=en']",17143694,https://doi.org/10.3109/s10165-004-0324-3, Mori 2004 ,additional,CD014884-bbs2-0108,,17143694,17143694,17143694,38,,,17143694
CD014884-bib-0139,"Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. ",The treatment of Kawasaki syndrome with intravenous gamma globulin, New England Journal of Medicine ,1986,315,    ,['citation-journal']," Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin.  New England Journal of Medicine 1986;315(6):3417.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJM198608073150601', 'https://www.ncbi.nlm.nih.gov/pubmed/2426590', 'https://scholar.google.com/scholar_lookup?title=The+treatment+of+Kawasaki+syndrome+with+intravenous+gamma+globulin&author=JW+Newburger&author=M+Takahashi&author=JC+Burns&author=AS+Beiser&author=KJ+Chung&author=CE+Duffy&publication_year=1986&hl=en']",2426590,https://doi.org/10.1056/NEJM198608073150601, Newburger 1986 ,additional,CD014884-bbs2-0109,,,,,1355,,,2426590
CD014884-bib-0140,"Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. ",A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome, New England Journal of Medicine ,1991,324,    ,['citation-journal']," Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.  New England Journal of Medicine 1991;324:16339. [DOI: 10.1056/NEJM199106063242305]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJM199106063242305', 'https://www.ncbi.nlm.nih.gov/pubmed/1709446', 'https://scholar.google.com/scholar_lookup?title=A+single+intravenous+infusion+of+gamma+globulin+as+compared+with+four+infusions+in+the+treatment+of+acute+Kawasaki+syndrome+&author=JW+Newburger&author=M+Takahashi&author=AS+Beiser&author=JC+Burns&author=J+Bastian&author=KJ+Chung&publication_year=1991&hl=en']",1709446,https://doi.org/10.1056/NEJM199106063242305, Newburger 1991 ,additional,CD014884-bbs2-0110,,,1709446,1709446,1133,https://www.nejm.org/doi/pdf/10.1056/NEJM199106063242305?articleTools=true,,1709446
CD014884-bib-0141,"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. ","Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association", Pediatrics ,2004,114,    ,['citation-journal']," Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.  Pediatrics 2004;114(6):170833. [DOI: 10.1542/peds.2004-2182]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1542/peds.2004-2182', 'https://www.ncbi.nlm.nih.gov/pubmed/15574639', 'https://scholar.google.com/scholar_lookup?title=Diagnosis,+treatment,+and+long-term+management+of+Kawasaki+disease:+a+statement+for+health+professionals+from+the+Committee+on+Rheumatic+Fever,+Endocarditis,+and+Kawasaki+Disease,+Council+on+Cardiovascular+Disease+in+the+Young,+American+Heart+Association+&author=JW+Newburger&author=M+Takahashi&author=MA+Gerber&author=MH+Gewitz&author=LY+Tani&author=JC+Burns&publication_year=2004&hl=en']",15574639,https://doi.org/10.1542/peds.2004-2182, Newburger 2004 ,additional,CD014884-bbs2-0111,,,,,,,,15574639
CD014884-bib-0142,"Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. ",Intravenous immunoglobulin for the treatment of Kawasaki disease in children, Cochrane Database of Systematic Reviews ,2003,,    ,['citation-journal']," Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children.  Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No: CD004000. [DOI: 10.1002/14651858.CD004000]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Intravenous+immunoglobulin+for+the+treatment+of+Kawasaki+disease+in+children&author=RM+Oates-Whitehead&author=JH+Baumer&author=L+Haines&author=S+Love&author=IK+Maconochie&author=A+Gupta&publication_year=2003&hl=en'],,, OatesWhitehead 2003 ,additional,CD014884-bbs2-0112,,,,,,,,
CD014884-bib-0143,"Olivieri L, Arling B, Friberg M, Sable C. ",Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography, Journal of the American Society of Echocardiography ,2009,22,    ,['citation-journal']," Olivieri L, Arling B, Friberg M, Sable C. Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography.  Journal of the American Society of Echocardiography 2009;22(2):159-64. [DOI: 10.1016/j.echo.2008.11.003] [PMID: 19084373]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.echo.2008.11.003', 'https://www.ncbi.nlm.nih.gov/pubmed/19084373', 'https://scholar.google.com/scholar_lookup?title=Coronary+artery+Z+score+regression+equations+and+calculators+derived+from+a+large+heterogeneous+population+of+children+undergoing+echocardiography+&author=L+Olivieri&author=B+Arling&author=M+Friberg&author=C+Sable&publication_year=2009&hl=en']",19084373,https://doi.org/10.1016/j.echo.2008.11.003, Olivieri 2008 ,additional,CD014884-bbs2-0113,,19084373,19084373,19084373,89,,,19084373
CD014884-bib-0144,"Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ",ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms, Nature Genetics ,2008,40,    ,['citation-journal']," Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.  Nature Genetics 2008;40(1):3542. [DOI: 10.1038/ng.2007.59]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1038/ng.2007.59', 'https://www.ncbi.nlm.nih.gov/pubmed/18084290', 'https://scholar.google.com/scholar_lookup?title=ITPKC+functional+polymorphism+associated+with+Kawasaki+disease+susceptibility+and+formation+of+coronary+artery+aneurysms+&author=Y+Onouchi&author=T+Gunji&author=JC+Burns&author=C+Shimizu&author=JW+Newburger&author=M+Yashiro&publication_year=2008&hl=en']",18084290,https://doi.org/10.1038/ng.2007.59, Onouchi 2008 ,additional,CD014884-bbs2-0114,,,,18084290,461,https://europepmc.org/articles/pmc2876982?pdf=render,,18084290
CD014884-bib-0145,"Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, et al. ",Common variants in CASP3 confer susceptibility to Kawasaki disease, Human Molecular Genetics ,2010,19,    ,['citation-journal']," Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease.  Human Molecular Genetics 2010;19(14):2898906. [DOI: 10.1093/hmg/ddq176]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/hmg/ddq176', 'https://www.ncbi.nlm.nih.gov/pubmed/20423928', 'https://scholar.google.com/scholar_lookup?title=Common+variants+in+CASP3+confer+susceptibility+to+Kawasaki+disease&author=Y+Onouchi&author=K+Ozaki&author=JC+Buns&author=C+Shimizu&author=H+Hamada&author=T+Honda&publication_year=2010&hl=en']",20423928,https://doi.org/10.1093/hmg/ddq176, Onouchi 2010 ,additional,CD014884-bbs2-0115,,,20423928,20423928,147,https://academic.oup.com/hmg/article-pdf/19/14/2898/17249296/ddq176.pdf,,20423928
CD014884-bib-0146,"Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai T, Hamada H, et al. ",A genome-wide association study identifies three new risk loci for Kawasaki disease, Nature Genetics ,2012,44,    ,['citation-journal']," Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai T, Hamada H, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease.  Nature Genetics 2012;44(5):51721. [DOI: 10.1038/ng.2220]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1038/ng.2220', 'https://www.ncbi.nlm.nih.gov/pubmed/22446962', 'https://scholar.google.com/scholar_lookup?title=A+genome-wide+association+study+identifies+three+new+risk+loci+for+Kawasaki+disease&author=Y+Onouchi&author=K+Ozaki&author=JC+Burns&author=C+Shimizu&author=T+Terai&author=H+Hamada&publication_year=2012&hl=en']",22446962,https://doi.org/10.1038/ng.2220, Onouchi 2012 ,additional,CD014884-bbs2-0116,,,,22446962,321,,,22446962
CD014884-bib-0147,,Review Manager Web (RevMan Web),,2022,,. Available at revman.cochrane.org.   ,['citation-other']," Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.    ",[],,, RevMan Web 2022 [Computer program] ,additional,CD014884-bbs2-0117,,41695702,,,,,,41695702
CD014884-bib-0148,"Rife E, Gedalia A. ",Kawasaki disease: an update, Current Rheumatology Reports ,2020,22,    ,['citation-journal']," Rife E, Gedalia A. Kawasaki disease: an update.  Current Rheumatology Reports 2020;22:75. [DOI: 10.1007/s11926-020-00941-4]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s11926-020-00941-4', 'https://www.ncbi.nlm.nih.gov/pubmed/32924089', 'https://scholar.google.com/scholar_lookup?title=Kawasaki+disease:+an+update&author=E+Rife&author=A+Gedalia&publication_year=2020&hl=en']",32924089,https://doi.org/10.1007/s11926-020-00941-4, Rife 2020 ,additional,CD014884-bbs2-0118,,32924089,,32924089,189,https://link.springer.com/content/pdf/10.1007/s11926-020-00941-4.pdf,,32924089
CD014884-bib-0149,"Rowley AH, Eckerley CA, Jck HM, Shulman ST, Baker SC. ",IgA plasma cells in vascular tissue of patients with Kawasaki syndrome, Journal of Immunology ,1997,159,    ,['citation-journal']," Rowley AH, Eckerley CA, Jck HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.  Journal of Immunology 1997;159(12):594655.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=IgA+plasma+cells+in+vascular+tissue+of+patients+with+Kawasaki+syndrome&author=AH+Rowley&author=CA+Eckerley&author=HM+Jck&author=ST+Shulman&author=SC+Baker&publication_year=1997&hl=en'],,, Rowley 1997 ,additional,CD014884-bbs2-0119,,9550392,,,,,,9550392
CD014884-bib-0150,"Sauvaget E, Bonello B, David M, Chabrol B, Dubus JC, Bosdure E. ",Resistant Kawasaki disease treated with anti-CD20, Journal of Pediatrics ,2012,160,    ,['citation-journal']," Sauvaget E, Bonello B, David M, Chabrol B, Dubus JC, Bosdure E. Resistant Kawasaki disease treated with anti-CD20.  Journal of Pediatrics 2012;160(5):875-6. [DOI: 10.1016/j.jpeds.2012.01.018] [PMID: 22341587]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jpeds.2012.01.018', 'https://www.ncbi.nlm.nih.gov/pubmed/22341587', 'https://scholar.google.com/scholar_lookup?title=Resistant+Kawasaki+disease+treated+with+anti-CD20&author=E+Sauvaget&author=B+Bonello&author=M+David&author=B+Chabrol&author=JC+Dubus&author=E+Bosdure&publication_year=2012&hl=en']",22341587,https://doi.org/10.1016/j.jpeds.2012.01.018, Sauvaget2012 ,additional,CD014884-bbs2-0120,,22341587,,22341587,21,,,22341587
CD014884-bib-0151,"Schnemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. ","Chapter 14: Completing Summary of findings tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021",,,,. Available from training.cochrane.org/handbook/archive/v6.2.   ,['citation-other']," Schnemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing Summary of findings tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.    ",[],,, Schnemann 2021 ,additional,CD014884-bbs2-0121,,,,,,,,
CD014884-bib-0152,"Tremoulet AH, Jain S, Jone PN, Best BM, Duxbury EH, Franco A, et al. ",Phase I/IIa trial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm, Journal of Pediatrics ,2019,215,    ,['citation-journal']," Tremoulet AH, Jain S, Jone PN, Best BM, Duxbury EH, Franco A, et al. Phase I/IIa trial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm.  Journal of Pediatrics 2019;215:10717.e12. [DOI: 10.1016/j.jpeds.2019.07.064]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jpeds.2019.07.064', 'https://scholar.google.com/scholar_lookup?title=Phase+I/IIa+trial+of+atorvastatin+in+patients+with+acute+Kawasaki+disease+with+coronary+artery+aneurysm+&author=AH+Tremoulet&author=S+Jain&author=PN+Jone&author=BM+Best&author=EH+Duxbury&author=A+Franco&publication_year=2019&hl=en']",,https://doi.org/10.1016/j.jpeds.2019.07.064, Tremoulet 2019 ,additional,CD014884-bbs2-0122,,,,31561960,32,https://escholarship.org/content/qt8tf831db/qt8tf831db.pdf?t=r5hpmo,,31561960
CD014884-bib-0153,"Uehara R, Yashiro M, Nakamura Y, Yanagawa H. ",Kawasaki disease in parents and children, Acta Paediatrica ,2003,92,    ,['citation-journal']," Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children.  Acta Paediatrica 2003;92:6947. [DOI: 10.1111/j.1651-2227.2003.tb00602.x]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1651-2227.2003.tb00602.x', 'https://www.ncbi.nlm.nih.gov/pubmed/12856980', 'https://scholar.google.com/scholar_lookup?title=Kawasaki+disease+in+parents+and+children&author=R+Uehara&author=M+Yashiro&author=Y+Nakamura&author=H+Yanagawa&publication_year=2003&hl=en']",12856980,https://doi.org/10.1111/j.1651-2227.2003.tb00602.x, Uehara 2003 ,additional,CD014884-bbs2-0123,,21040190,,12856980,149,,,12856980
CD014884-bib-0154,"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. ",An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet ,2020,395,    ,['citation-journal']," Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.  Lancet 2020;395:1771-8.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(20)31103-X', 'https://www.ncbi.nlm.nih.gov/pubmed/32410760', 'https://scholar.google.com/scholar_lookup?title=An+outbreak+of+severe+Kawasaki-like+disease+at+the+Italian+epicentre+of+the+SARS-CoV-2+epidemic:+an+observational+cohort+study+&author=L+Verdoni&author=A+Mazza&author=A+Gervasoni&author=L+Martelli&author=M+Ruggeri&author=M+Ciuffreda&publication_year=2020&hl=en']",32410760,https://doi.org/10.1016/S0140-6736(20)31103-X, Verdoni 2020 ,additional,CD014884-bbs2-0124,,,32410760,32410760,2062,http://www.thelancet.com/article/S014067362031103X/pdf,,32410760
CD014884-bib-0155,"Yamaji N, da Silva Lopes K, Shoda T, Ishitsuka K, Kobayashi T, Ota E, et al. ",TNF- blockers for the treatment of Kawasaki disease in children, Cochrane Database of Systematic Reviews ,2019,,    ,['citation-journal']," Yamaji N, da Silva Lopes K, Shoda T, Ishitsuka K, Kobayashi T, Ota E, et al. TNF- blockers for the treatment of Kawasaki disease in children.  Cochrane Database of Systematic Reviews 2019, Issue 8. Art. No: CD012448. [DOI: 10.1002/14651858.CD012448.pub2]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD012448.pub2', 'https://www.ncbi.nlm.nih.gov/pubmed/31425625', 'https://scholar.google.com/scholar_lookup?title=TNF-+blockers+for+the+treatment+of+Kawasaki+disease+in+children&author=N+Yamaji&author=K+daSilvaLopes&author=T+Shoda&author=K+Ishitsuka&author=T+Kobayashi&author=E+Ota&publication_year=2019&hl=en']",31425625,https://doi.org/10.1002/14651858.CD012448.pub2, Yamaji 2019 ,additional,CD014884-bbs2-0125,,,,31425625,48,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953355,,31425625
CD014884-bib-0156,"Yashiro M, Nakamura Y, Yanagawa H. ",Clinical features of patients with Kawasaki disease whose parents had the same disease, Archives of Pediatrics and Adolescent Medicine ,2004,158,    ,['citation-journal']," Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease.  Archives of Pediatrics and Adolescent Medicine 2004;158:11669.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/15583102', 'https://scholar.google.com/scholar_lookup?title=Clinical+features+of+patients+with+Kawasaki+disease+whose+parents+had+the+same+disease&author=M+Yashiro&author=Y+Nakamura&author=H+Yanagawa&publication_year=2004&hl=en']",15583102,, Yashiro 2004 ,additional,CD014884-bbs2-0126,,15583102,15583102,,,,,15583102
CD014884-bib-0157,"Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BYK. ",Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease, Current Opinion in Pharmacology ,2020,54,    ,['citation-journal']," Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BYK. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.  Current Opinion in Pharmacology 2020;54:110.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.coph.2020.08.008', 'https://www.ncbi.nlm.nih.gov/pubmed/32619934', 'https://scholar.google.com/scholar_lookup?title=Current+pharmacological+intervention+and+development+of+targeting+IVIG+resistance+in+Kawasaki+disease+&author=RL+Zhang&author=HH+Lo&author=C+Lei&author=N+Ip&author=J+Chen&author=BYK+Law&publication_year=2020&hl=en']",32619934,https://doi.org/10.1016/j.coph.2020.08.008, Zhang 2020 ,additional,CD014884-bbs2-0127,,32956895,32956895,32956895,28,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500898,,32619934
CD014884-bib-0074,Chang YC. ,Two different large dosage of gamma-immunoglobulin for the treatment of Kawasaki disease, Sichuan Medical Journal ,2007,28,    ,['citation-journal'], Chang YC. Two different large dosage of gamma-immunoglobulin for the treatment of Kawasaki disease.  Sichuan Medical Journal 2007;28(7):801. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Two+different+large+dosage+of+gamma-immunoglobulin+for+the+treatment+of+Kawasaki+disease&author=YC+Chang&publication_year=2007&hl=en']",,, Chang 2007 {published data only}  ,awaiting_assessment,CD014884-bbs2-0045,,,,,,,,
CD014884-bib-0075,Chang WH. ,The different dosage of gamma-immunoglobulin in treating of Kawasaki disease - a clinical study, Journal of Jilin Medical College ,2008,29,    ,['citation-journal'], Chang WH. The different dosage of gamma-immunoglobulin in treating of Kawasaki disease - a clinical study.  Journal of Jilin Medical College 2008;29(4):199-201. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=The+different+dosage+of+gamma-immunoglobulin+in+treating+of+Kawasaki+disease+-+a+clinical+study+&author=WH+Chang&publication_year=2008&hl=en']",,, Chang 2008 {published data only}  ,awaiting_assessment,CD014884-bbs2-0046,,,,,,,,
CD014884-bib-0076,"Chen PC, Shi WZ. ",Medium dose of gamma-immunoglobulin for the treatment of Kawasaki disease - a clinical observation, Zhejiang Clinical Medicine ,2006,8,    ,['citation-journal']," Chen PC, Shi WZ. Medium dose of gamma-immunoglobulin for the treatment of Kawasaki disease - a clinical observation.  Zhejiang Clinical Medicine 2006;8(3):308. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Medium+dose+of+gamma-immunoglobulin+for+the+treatment+of+Kawasaki+disease+-+a+clinical+observation+&author=PC+Chen&author=WZ+Shi&publication_year=2006&hl=en']",,, Chen 2006 {published data only}  ,awaiting_assessment,CD014884-bbs2-0047,,,,,,,,
CD014884-bib-0077,"Fu CN, Chen HP. ",Comparison of the therapeutic effects of different dose intravenous gamma-immunoglobulin in Kawasaki disease, China Modern Drug Application ,2010,4,    ,['citation-journal']," Fu CN, Chen HP. Comparison of the therapeutic effects of different dose intravenous gamma-immunoglobulin in Kawasaki disease.  China Modern Drug Application 2010;4(7):121-2. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+the+therapeutic+effects+of+different+dose+intravenous+gamma-immunoglobulin+in+Kawasaki+disease+&author=CN+Fu&author=HP+Chen&publication_year=2010&hl=en']",,, Fu 2010 {published data only}  ,awaiting_assessment,CD014884-bbs2-0048,,,,,,,,
CD014884-bib-0078,"Ho HH, Chang Q, Lee JY. ",Different dosage of intravenous immunoglobulin for the treatment of Kawasaki disease - the observation of therapeutic effect, FJ Medical Journal ,2003,25,    ,['citation-journal']," Ho HH, Chang Q, Lee JY. Different dosage of intravenous immunoglobulin for the treatment of Kawasaki disease - the observation of therapeutic effect.  FJ Medical Journal 2003;25(2):49-50. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Different+dosage+of+intravenous+immunoglobulin+for+the+treatment+of+Kawasaki+disease+-+the+observation+of+therapeutic+effect+&author=HH+Ho&author=Q+Chang&author=JY+Lee&publication_year=2003&hl=en']",,, Ho 2003 {published data only}  ,awaiting_assessment,CD014884-bbs2-0049,,,,,,,,
CD014884-bib-0079,Ho C. ,Comparison of therapeutic efficacy of two intravenous gamma-immunoglobulin regimen in acute Kawasaki disease, Hebei Medicine ,2004,26,    ,['citation-journal'], Ho C. Comparison of therapeutic efficacy of two intravenous gamma-immunoglobulin regimen in acute Kawasaki disease.  Hebei Medicine 2004;26(4):323. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+therapeutic+efficacy+of+two+intravenous+gamma-immunoglobulin+regimen+in+acute+Kawasaki+disease+&author=C+Ho&publication_year=2004&hl=en']",,, Ho 2004 {published data only}  ,awaiting_assessment,CD014884-bbs2-0050,,,,,,,,
CD014884-bib-0080,"Juan HL, Xiang RL, Liang GA, Lu HP. ",The effect of different IVIG dosage on CD4+ /CD8+ of children with Kawasaki disease, Pediatric Pharmacological Magazine ,2003,9,    ,['citation-journal']," Juan HL, Xiang RL, Liang GA, Lu HP. The effect of different IVIG dosage on CD4+ /CD8+ of children with Kawasaki disease.  Pediatric Pharmacological Magazine 2003;9(3):18-9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+different+IVIG+dosage+on+CD4++/CD8++of+children+with+Kawasaki+disease&author=HL+Juan&author=RL+Xiang&author=GA+Liang&author=HP+Lu&publication_year=2003&hl=en']",,, Juan 2003 {published data only}  ,awaiting_assessment,CD014884-bbs2-0051,,,,,,,,
CD014884-bib-0081,"Juan C, Yang HB, Juan J, Ho XL. ",Comparison of therapeutic efficacy of two large dosage intravenous gamma-immunoglobulin regimens in pediatric Kawasaki disease, Practical Clinical Medicine ,2005,8,    ,['citation-journal']," Juan C, Yang HB, Juan J, Ho XL. Comparison of therapeutic efficacy of two large dosage intravenous gamma-immunoglobulin regimens in pediatric Kawasaki disease.  Practical Clinical Medicine 2005;8(3):48-9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+therapeutic+efficacy+of+two+large+dosage+intravenous+gamma-immunoglobulin+regimens+in+pediatric+Kawasaki+disease+&author=C+Juan&author=HB+Yang&author=J+Juan&author=XL+Ho&publication_year=2005&hl=en']",,, Juan 2005 {published data only}  ,awaiting_assessment,CD014884-bbs2-0052,,,,,,,,
CD014884-bib-0082,"Juan C, Cai XJ. ",Comparison of therapeutic efficacy of two gamma-immunoglobulin regimens in acute Kawasaki disease, Qingdao Medicine and Health ,2006,38,    ,['citation-journal']," Juan C, Cai XJ. Comparison of therapeutic efficacy of two gamma-immunoglobulin regimens in acute Kawasaki disease.  Qingdao Medicine and Health 2006;38(3):175-6. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+therapeutic+efficacy+of+two+gamma-immunoglobulin+regimens+in+acute+Kawasaki+disease+&author=C+Juan&author=XJ+Cai&publication_year=2006&hl=en']",,, Juan 2006 {published data only}  ,awaiting_assessment,CD014884-bbs2-0053,,,,,,,,
CD014884-bib-0083,"Kuo L, Chang HY, Dou JL, Xu FX, Zhai YL. ",Different dosage of intravenous gamma-immunoglobulin for the treatment of Kawasaki disease. The observation of therapeutic effect and nursing experience, China Practical Clinical Medicine ,2009,3,    ,['citation-journal']," Kuo L, Chang HY, Dou JL, Xu FX, Zhai YL. Different dosage of intravenous gamma-immunoglobulin for the treatment of Kawasaki disease. The observation of therapeutic effect and nursing experience.  China Practical Clinical Medicine 2009;3(7):116-7. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Different+dosage+of+intravenous+gamma-immunoglobulin+for+the+treatment+of+Kawasaki+disease.+The+observation+of+therapeutic+effect+and+nursing+experience+&author=L+Kuo&author=HY+Chang&author=JL+Dou&author=FX+Xu&author=YL+Zhai&publication_year=2009&hl=en']",,, Kuo 2009 {published data only}  ,awaiting_assessment,CD014884-bbs2-0054,,,,,,,,
CD014884-bib-0084,"Li HL, Liao Y. ",Analysis of the therapeutic efficacy of a single dose gamma-immunoglobulin for the treatment of Kawasaki disease in thirty three children, Journal of Gannan Medical University ,2008,28,    ,['citation-journal']," Li HL, Liao Y. Analysis of the therapeutic efficacy of a single dose gamma-immunoglobulin for the treatment of Kawasaki disease in thirty three children.  Journal of Gannan Medical University 2008;28(1):36-8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Analysis+of+the+therapeutic+efficacy+of+a+single+dose+gamma-immunoglobulin+for+the+treatment+of+Kawasaki+disease+in+thirty+three+children+&author=HL+Li&author=Y+Liao&publication_year=2008&hl=en']",,, Li 2008 {published data only}  ,awaiting_assessment,CD014884-bbs2-0055,,,,,,,,
CD014884-bib-0085,Li CK. ,Two different intravenous gamma-immunoglobulin regimens in the treatment acute Kawasaki disease - an observation of therapeutic efficacy, Practical Clinical Medicine ,2009,10,    ,['citation-journal'], Li CK. Two different intravenous gamma-immunoglobulin regimens in the treatment acute Kawasaki disease - an observation of therapeutic efficacy.  Practical Clinical Medicine 2009;10(12):60-2. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Two+different+intravenous+gamma-immunoglobulin+regimens+in+the+treatment+acute+Kawasaki+disease+-+an+observation+of+therapeutic+efficacy+&author=CK+Li&publication_year=2009&hl=en']",,, Li 2009 {published data only}  ,awaiting_assessment,CD014884-bbs2-0056,,,,,,,,
CD014884-bib-0086,"Liao J, He KJ. ",The clinical study of different dosage immune globulin in treating Kawasaki in intravenous injection, China Healthcare Innovation ,2007,2,    ,['citation-journal']," Liao J, He KJ. The clinical study of different dosage immune globulin in treating Kawasaki in intravenous injection.  China Healthcare Innovation 2007;2(22):8-9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+clinical+study+of+different+dosage+immune+globulin+in+treating+Kawasaki+in+intravenous+injection+&author=J+Liao&author=KJ+He&publication_year=2007&hl=en']",,, Liao 2007 {published data only}  ,awaiting_assessment,CD014884-bbs2-0057,,,,,,,,
CD014884-bib-0087,Liu HM. ,The exploration of intravenous immunoglobulin dosage for the treatment of Kawasaki disease, Shantung Medicine ,2000,40,    ,['citation-journal'], Liu HM. The exploration of intravenous immunoglobulin dosage for the treatment of Kawasaki disease.  Shantung Medicine 2000;40(8):23-4. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=The+exploration+of+intravenous+immunoglobulin+dosage+for+the+treatment+of+Kawasaki+disease+&author=HM+Liu&publication_year=2000&hl=en']",,, Liu 2000 {published data only}  ,awaiting_assessment,CD014884-bbs2-0058,,,,,,,,
CD014884-bib-0088,Liu TC. ,The observation of therapeutic effect of intravenous gamma-immunoglobulin in Kawasaki disease, Modern Journal of Integrated Traditional Chinese and Western Medicine ,2004,13,    ,['citation-journal'], Liu TC. The observation of therapeutic effect of intravenous gamma-immunoglobulin in Kawasaki disease.  Modern Journal of Integrated Traditional Chinese and Western Medicine 2004;13(4):451. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=The+observation+of+therapeutic+effect+of+intravenous+gamma-immunoglobulin+in+Kawasaki+disease+&author=TC+Liu&publication_year=2004&hl=en']",,, Liu 2004 {published data only}  ,awaiting_assessment,CD014884-bbs2-0059,,,,,,,,
CD014884-bib-0089,"Liu M, Cheng J, Luo Q. ",Comparison of therapeutic efficacy of two intravenous gamma-immunoglobulin regimens in children with Kawasaki disease, China Eugenics and Hereditary Magazine ,2009,17,    ,['citation-journal']," Liu M, Cheng J, Luo Q. Comparison of therapeutic efficacy of two intravenous gamma-immunoglobulin regimens in children with Kawasaki disease.  China Eugenics and Hereditary Magazine 2009;17(2):117-8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+therapeutic+efficacy+of+two+intravenous+gamma-immunoglobulin+regimens+in+children+with+Kawasaki+disease+&author=M+Liu&author=J+Cheng&author=Q+Luo&publication_year=2009&hl=en']",,, Liu 2009 {published data only}  ,awaiting_assessment,CD014884-bbs2-0060,,,,,,,,
CD014884-bib-0090,"Lu JX, Zheng ZL. ",Therapeutic effects of intravenous immune globulin on Kawasaki disease, Oinghai Medical Magazine ,2003,33,    ,['citation-journal']," Lu JX, Zheng ZL. Therapeutic effects of intravenous immune globulin on Kawasaki disease.  Oinghai Medical Magazine 2003;33(5):16-8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Therapeutic+effects+of+intravenous+immune+globulin+on+Kawasaki+disease&author=JX+Lu&author=ZL+Zheng&publication_year=2003&hl=en']",,, Lu 2003 {published data only}  ,awaiting_assessment,CD014884-bbs2-0061,,,,,,,,
CD014884-bib-0091,"Peng CM, Xiao Q, Chen YL, Su Y. ",A study on different dose of intravenous immunoglobulins for treating Kawasaki disease, Journal of Nanhua University (Medical Edition) ,2001,29,    ,['citation-journal']," Peng CM, Xiao Q, Chen YL, Su Y. A study on different dose of intravenous immunoglobulins for treating Kawasaki disease.  Journal of Nanhua University (Medical Edition) 2001;29(6):581-3. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+study+on+different+dose+of+intravenous+immunoglobulins+for+treating+Kawasaki+disease&author=CM+Peng&author=Q+Xiao&author=YL+Chen&author=Y+Su&publication_year=2001&hl=en']",,, Peng 2001 {published data only}  ,awaiting_assessment,CD014884-bbs2-0062,,,,,,,,
CD014884-bib-0092,Teng MY. ,Comparison of therapeutic efficacy of two gamma-immunoglobulin regimens in Kawasaki disease, International Medical Health Reports ,2005,11,    ,['citation-journal'], Teng MY. Comparison of therapeutic efficacy of two gamma-immunoglobulin regimens in Kawasaki disease.  International Medical Health Reports 2005;11(2):33-4. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+therapeutic+efficacy+of+two+gamma-immunoglobulin+regimens+in+Kawasaki+disease+&author=MY+Teng&publication_year=2005&hl=en']",,, Teng 2005 {published data only}  ,awaiting_assessment,CD014884-bbs2-0063,,,,,,,,
CD014884-bib-0093,Yao SH. ,The observation of therapeutic efficacy of different intravenous gamma-immunoglobulin for the treatment in sixty-four children with Kawasaki disease, China Community Physician ,2009,11,    ,['citation-journal'], Yao SH. The observation of therapeutic efficacy of different intravenous gamma-immunoglobulin for the treatment in sixty-four children with Kawasaki disease.  China Community Physician 2009;11(213):68-9. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=The+observation+of+therapeutic+efficacy+of+different+intravenous+gamma-immunoglobulin+for+the+treatment+in+sixty-four+children+with+Kawasaki+disease+&author=SH+Yao&publication_year=2009&hl=en']",,, Yao 2009 {published data only}  ,awaiting_assessment,CD014884-bbs2-0064,,,,,,,,
CD014884-bib-0094,Yen P. ,The observation of therapeutic efficacy of different intravenous gamma-immunoglobulin for the treatment in Kawasaki disease, Community Medical Magazine ,2007,5,    ,['citation-journal'], Yen P. The observation of therapeutic efficacy of different intravenous gamma-immunoglobulin for the treatment in Kawasaki disease.  Community Medical Magazine 2007;5(23):11. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=The+observation+of+therapeutic+efficacy+of+different+intravenous+gamma-immunoglobulin+for+the+treatment+in+Kawasaki+disease+&author=P+Yen&publication_year=2007&hl=en']",,, Yen 2007 {published data only}  ,awaiting_assessment,CD014884-bbs2-0065,,,,,,,,
CD014884-bib-0095,"Yuan YF, Kuai WX. ",The application of gamma-immunoglobulin for pediatric Kawasaki disease, Shanxi Medical Magazine ,2009,38,    ,['citation-journal']," Yuan YF, Kuai WX. The application of gamma-immunoglobulin for pediatric Kawasaki disease.  Shanxi Medical Magazine 2009;38(4):365-6. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+application+of+gamma-immunoglobulin+for+pediatric+Kawasaki+disease&author=YF+Yuan&author=WX+Kuai&publication_year=2009&hl=en']",,, Yuan 2009 {published data only}  ,awaiting_assessment,CD014884-bbs2-0066,,,,,,,,
CD014884-bib-0096,"Yueh AH, Tian QL, Li H. ",The observation of therapeutic efficacy of intravenous gamma-immunoglobulin for the treatment in fifty-six children with Kawasaki disease, Clinical Gathering ,2006,21,    ,['citation-journal']," Yueh AH, Tian QL, Li H. The observation of therapeutic efficacy of intravenous gamma-immunoglobulin for the treatment in fifty-six children with Kawasaki disease.  Clinical Gathering 2006;21(13):962-3. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+observation+of+therapeutic+efficacy+of+intravenous+gamma-immunoglobulin+for+the+treatment+in+fifty-six+children+with+Kawasaki+disease+&author=AH+Yueh&author=QL+Tian&author=H+Li&publication_year=2006&hl=en']",,, Yueh 2006 {published data only}  ,awaiting_assessment,CD014884-bbs2-0067,,,,,,,,
CD014884-bib-0158,"Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T. ",Intravenous immunoglobulin for the treatment of Kawasaki disease, Cochrane Database of Systematic Reviews ,2021,,    ,['citation-journal']," Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T. Intravenous immunoglobulin for the treatment of Kawasaki disease.  Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No: CD014884. [DOI: 10.1002/14651858.CD014884]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Intravenous+immunoglobulin+for+the+treatment+of+Kawasaki+disease&author=C+Broderick&author=S+Kobayashi&author=M+Suto&author=S+Ito&author=T+Kobayashi&publication_year=2021&hl=en'],,, Broderick 2021 ,other_versions,CD014884-bbs2-0128,,36695415,,,,,,36695415
